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1. Synthesis of benzo[1,2-b;5,6-b']dithiophenes and their subsequent 
desymmetrization 
 
1.1    Introduction 
Benzo[b]thiophenes show a wide range of pharmacological activities, such as estrogen 
receptor modulating activity, tubulin binding activity, activity as MRP1, angiogenesis and 
thrombin inhibitors, antiinflammatory activity, and antifungal activity.1 More complex, 
annulated thiophene derivatives often contain a low singlet-triplet energy gap and are 
important core structures of magnetic and electronic materials,2 such as organic ferromagnets, 
conductors, transistors, photovoltaic cells and organic light-emitting diodes (OLEDs).3 
Therefore, the synthesis and properties of rigid benzothiophene-fused aromatic compounds 
has been extensively studied in recent years.  
The molecular structure and their mechanism of formation are of substantial biological and 
industrial importance. Miura and coworkers have recently reported the synthesis of various 
3,7-diarylbenzo[1,2-b;4,5-b']dithiophenes4 by twofold Suzuki-Miyaura and Sonogashira cross 
coupling reactions of 3,7-dichlorobenzo[1,2-b;4,5-b']dithiophenes. The basic known 
methodology, the cyclization of thionyl chloride with cinnamic acids to give benzophenones, 
was first reported by Krubsack and Higa.7a The latter compounds were first prepared by Ried5 
and Karminski-Zamola6 and their coworkers by cyclization of 1,4-phenylenediacrylic acid 
with thionyl chloride and subsequent addition of a nucleophile. Herein, in this chapter, a 
number of new experimental data has been presented related to the unambiguous structural 
evidences that several of the earlier reported structures, 3,7-dichlorobenzo[1,2-b;4,5-
b']dithiophenes (2'), are wrong and that, by contrast, 3,8-dichlorobenzo[1,2-b;5,6-
b']dithiophenes (2) are formed (Figure 1). As a consequence, the structures of numerous 
arylated dithiophenes prepared by cross coupling reactions of the parent chlorinated 
derivatives have to be revised as well.  
 
1.2 Results and discussion 
In 1980, Ried and Oremek reported 5 that the reaction of 1,4-phenylenediacrylic acid with 
thionyl chloride, in the presence of catalytic amounts of pyridine, afforded the diacid 
dichloride A' as a reactive intermediate which was subsequently trapped with methanol as a 
nucleophile to give the 3,7-dichlorobenzo[1,2-b;4,5-b']dithiophene 2' (Scheme 2). In their 
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original report,5 Ried and coworkers characterized their product by 1H NMR, IR and MS 
spectroscopy and by elemental analysis (Scheme 1). It has been theorized that, alternatively, 
the isomeric 3,7-dichlorobenzo[1,2-b;5,6-b']dithiophene 2 could have been formed. But they 
decided that isomer 2' is more likely based on analysis of the IR bands in the fingerprint 
region because more reliable methods were not available at that time. As the possible 
resulting benzodithiophene cores show molecular symmetry, they have chemically equivalent 
protons at the benzene ring which can not be differentiated by NMR techniques.  
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Figure 1. Our synthetic approach 
In 1995, Karminski-Zamola referred to the original report of 1980 and reported the 
employment of anilines as the nucleophile and formation of 3,7-dichlorobenzo[1,2-b;4,5-
b']dithiophene diamides. In 2009, Miura used n-butanol as the nucleophile and reported the 
synthesis of diester 3' (Scheme 2).4a This product was transformed into various symmetrical 
diarylated 3,7-dichlorobenzo[1,2-b;5,6-b']dithiophenes by twofold Suzuki-Miyaura cross-
coupling reactions of the chloride groups. None of all these structures reported were 
unambigiously confirmed by X-ray crystal structure analyses or detailed NMR studies.  
8 
 
COOH
COOH
S
S
Cl
Cl
O
Cl
O
Cl
S
S
Cl
Cl
O
OCH 3
O
OCH 3
2) CH3OH
COOH
HOOC
S
S
Cl
O
O
Cl
Cl
Cl
S
S
Cl
O
Cl
O
Cl
Cl
S
S
OCH 3
O
O
OCH 3
Cl
Cl
S
S
OCH 3
O
OCH 3
O
Cl
Cl
2) CH3OH
2) CH3OH
1) SOCl2
1) SOCl2
m-Phenylenediacrylic acid
o-Phenylenediacrylic acid
 
 Scheme 1. Cyclization pattern of o-, m-, p-phenylenediacrylic acids 
We have found that the reaction of 1,4-phenylenediacrylic acid with thionyl chloride (5h, 140 
°C), in the presence of catalytic amounts of pyridine, and subsequent addition of methanol 
(2h, reflux), following the conditions reported by Ried,5 afforded a yellow crystalline solid. 
To our surprise, an X-ray crystal structure analysis revealed that the product was 
dichlorobenzo[1,2-b;5,6-b']dithiophene 2 instead of the expected isomeric 3,7-
dichlorobenzo[1,2-b;4,5-b']dithiophene 2' (Scheme 2, Figure 1). 
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Scheme 2. Synthesis of 2 and 3; i,1) SOCl2, pyridine, 5 h, 140 °C; 2) ROH, 2 h, reflux 
Phenylenediacrylic acids (o-, m- and p-isomers) cyclize with thionyl chloride to furnish their 
relative esters (Scheme 1).5 We reinvestigated the previous work of Ried and Miura and their 
coworkers.  
To confirm that product 2' does not simply represent a by-product which crystallized in the 
presence of 2, special attention was given to the work-up procedure. The NMR data of the 
crystals were identical with the rest of the material. The moderate isolated yield of 2 (57 %) 
can be explained by losses during the chromatographic purification. The isomeric product 2' 
was not formed which was confirmed by NMR measurements of the crude product (before 
chromatographic purification). 
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Figure 1. Ortep plot of 2 
Di(butyl)ester 3' was also synthesized, repeating the same method which was reported by 
Miura in 2009.4 The cyclization of 1,4-phenylenediacrylic acid with SOCl2 and subsequent 
reaction with n-butanol (instead of methanol) again afforded a yellow solid. The structure, 
which was unambiguously confirmed by X-ray crystal structure analysis, turned out to be 3,8-
dichlorobenzo[1,2-b;5,6-b']dithiophene 3 instead of 3,7-dichlorobenzo[1,2-b;4,5-
b']dithiophene 3' (Figure 2). 
 
Figure 2. Ortep plot of 3 
Because of the importance of these finding, we aimed to get additional structural proofs by 
NMR through desymmetrization of parent substrates. The NMR data of our product were 
identical with those reported by Miura and coworkers. 9 Due to the symmetrical structures of 
both dithiophenes 3 and 3', similar NMR data are expected and the exact structural 
elucidation by NMR is not possible. These chemically equivalent protons will resonate at the 
same chemical shift. The aromatic protons Ha appear as a singlet with the integration of two 
11 
 
protons. However, this observation is compatible with both isomers 3 and 3', since no 
coupling between the two aromatic protons Ha is expected (the protons are chemically and 
magnetically equivalent) (Figure 3). The practical assessment of molecular symmetry can not 
be decided through simple NMR values. 
 
Figure 3. 1H NMR spectrum of compound 3 in CDCl3 at 300 MHz  
The desymmetrization approach was explored under the optimized reaction conditions 
(Scheme 3). The symmetrical substrate 3 gave rise to the desymmetrized products 
(unsymmetrical derivatives 5a-c). These findings provide a clear basis to decide about the 
structure of the parent substrate independently, even if not any X-ray structure would be 
available. The mono-Suzuki-Miyaura cross-coupling reaction of 3 with 1.2 equiv of 
arylboronic acids 4a-c afforded the 3-aryl-8-chlorobenzo[1,2-b;5,6-b']dithiophenes 5a-c in 
very good yields (Scheme 2, Table 1).8 The best yields were obtained when Pd(PPh3)4 ( mol 
%) and K3PO4 (1.5 equiv.) were used as the catalyst and base, respectively. The reactions 
were carried out in dioxane (120 °C, 4h). The arylboronic acids were chosen in the sense that 
12 
 
their 1H NMR signals would not disturb the structure elucidation of the aromatic core 
structure (vide infra). 
O
OO
O
Bu BuSS
ArCl
H aHb
SS
Cl
O
OBuBuO
O
Cl ArB(OH) 2
i
3 5  
Scheme 3. Synthesis of 5a-c. Conditions: i, 3 (1.0 equiv.), ArB(OH)2 (1.2 equiv.), Pd(PPh3)4                      
(5 mol %), K3PO4 (2.0 equiv.), dioxane, 120 °C, 4h  
 
      Table 1. Synthesis of 5a-c 
4 Ar % (5)a 
a 2-MeO-5-FC6H3 82 
b 2-MeO-5-ClC6H3 87 
c 2-(MeO)C6H4 90 
            a Yields of isolated compounds 
 
Inspection of the 1H NMR spectra of 5a-c clearly showed that the two aromatic protons Ha 
and Hb are, as expected, chemically and magnetically different and resonate as characteristic 
dublets at approx. δ = 7.74 and 7.36 ppm with coupling constants of about 8.8 Hz (Figure 4). 
These results are only compatible with the structures of 3-aryl-7-chlorobenzo[1,2-b;5,6-
b']dithiophenes 5a-c, but not with the corresponding isomeric 3-aryl-7-chlorobenzo[1,2-b;4,5-
b']dithiophenes. In the latter case, no significant coupling is possible for the aromatic protons 
Ha and Hb. As a consequence, the NMR experiments of 5a-c clearly confirm the structure of 
dichlorodithiophene 3 as well, as no change of the aromatic core can be expected during the 
coupling reactions.  
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Figure 4. 1H NMR Spectrum of 5b in CDCl3 at 300 MHz  
Moreover, additional structural informations were obtained by the effective diarylation of 
dichlorobenzo[1,2-b;5,6-b']dithiophene moiety 3 (Scheme 4, Table 2). The diarylation 
coupling reactions initially failed using Pd(PPh3)4 (5 mol %) as catalyst, but successfully 
worked out adding biaryl monophosphine ligand SPhos (L) (10 mol %) which has been 
recently developed by Buchwald and coworkers. 4b SPhos is an organophosphorus compound 
derived from biphenyl. Its palladium complexes exhibit high activity for Suzuki coupling 
reactions involving aryl chlorides, which are less or unreactive with other palladium 
complexes. These ligands have convenient handling characteristics, since they are air-stable 
(Figure 5). The bis(butoxycarbonyl)dichlorobenzo[b]dithiophene 3 was employed as a 
platform for the Suzuki-Miyaura cross coupling reaction, using palladium catalyst Pd(PPh3)4 
(5 mol %) along with Buchwald ligand SPhos (10 mol %), for a facile preparation of 
diarylbenzodithiophenes (Scheme 4). The  resulting diarylated benzo[1,2-b;5,6-
14 
 
b']dithiophenes again have a symmetrical core where both the equivalent protons Ha can not 
be differentiated to give separate chemical shift values. 
 
SS COOBuBuOOC
H aHa
SS
Cl
O
OBuBuO
O
Cl
i
ArB(OH)2
RR
3 6  
 
Scheme 4. Synthesis of 6b,c. Conditions: i, 3 (1.0 equiv.), ArB(OH)2 (2.5 equiv.), 
Pd(PPh3)4 (5mol %), SPhos ligand (10 mol %), K3PO4 (4.0 equiv.), dioxane, 120-130 
°C, 6-8h  
 
                      
iPrPr i
PCy 2
iPr
OMeMeO
PCy 2
Cy = Cyclohexyl
XPhos SPhos  
Figure 5. Buchwald ligands 4b 
The resulting diarylated benzodithiophene products 6b,c are again symmetrical where 
identical NMR data are expected and a clear structural differentiation by NMR is not possible. 
The aromatic protons Ha appear as a singlet with the integration of two protons. However, this 
observation is compatible with both parent isomers 3 and 3', since no coupling between the 
two aromatic protons Ha is expected (the protons are chemically and magnetically equivalent) 
(Figure 6).  
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           Table 2. Synthesis of 6b,c 
4 Ar % (6)a 
b 2-MeO-5-ClC6H3 62 
c 2-MeO-5-C6H4 74 
          a Yields of isolated compounds 
 
 
Figure 6. 1H NMR Spectrum of 5b in CDCl3 at 300 MHz  
Due to the striking difference between our results and those reported earlier, the cyclization 
reaction of 1,4-phenylenediacrylic acid with thionyl chloride, pyridine and methanol or n-
butanol was repeated five times under the original conditions and always the same result was 
observed (formation of 2 and 3 as the main products, respectively). The reaction was also 
carried out in the absence of pyridine, but no significant change of the product distribution 
was observed. 
Looking at the literature that after the first publication of Krubsack nobody has investigated 
the real mechanism of this cyclization. Actually, Krubsack reported that the cyclization is not 
regio-selective, thus, an investigation on the actual mechanism of this regio-cyclization to 
16 
 
rationalize the formation of the more hindered benzo[b]dithiophenes was carried out on 
further computational basis.  
 
Computations 
To get some rationalization of the observed selectivity in favour of 3,6-dichlorobenzo[1,2-
b;5,6-b']dithiophene A instead of 3,7-dichlorobenzo[1,2-b;4,5-b']dithiophene A’ (Scheme 5), 
the cyclization of 1 with thionyl chloride was studied by Density Functional Theory 
calculations (DFT) at the B3LYP level of theory using a 6-31G* basis set. The DFT 
calculations show that isomer A is thermodynamically more stable than isomer A’ (by 5.5 
kJ/mol, Table 3). However, the thermodynamic stability is unlikely to be the reason for the 
selectivity of the reaction because the reaction is irreversible. Therefore, possible mechanistic 
intermediates were studied by DFT calculations. The calculations were carried out for 
analogues of the mechanistic intermediates suggested by Krubsack et al. for the reaction of 
trans-cinnamic acid with thionyl chloride.  
We assumed that the two cyclization reactions of diacrylate 1 occur sequentially and not at the 
same time. Thus, the first cyclization of 1 with thionyl chloride afforded the planar 
intermediate 1A which reacts with a second equivalent of thionyl chloride to give the 
rotamers ImA and ImA’ (Scheme 6). In principle, two diastereomers can be formed for each 
rotamer. However, only one diastereomer was considered because the energetic difference 
between the two diastereomers is low. 
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Scheme 5. Formation of ImA and ImA’ 
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In analogy to the mechanistic studies of Krubsack et al. for trans-cinnamic acid, three 
possible paths for the transformation of ImA and ImA’ to A and A’ can be proposed, 
respectively (Schemes 6 and 7). This includes a direct electrophilic substitution (path 1), or 
electrophilic substitution via intermediate ImBA which could be formed by 1,2-elimination of 
hydrogen chloride (path 2), or rearrangement of intermediate ImBA to episulfide ImA3 (path 
3).  
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Scheme 6. Proposed mechanism for the formation of  3,8-dichlorobenzo[1,2-b;4,5-b']dithiophene A’ 
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Scheme 7. Proposed mechanism for the formation of 3,8-dichlorobenzo[1,2-b;5,6-b']dithiophene A. 
 
The energies of the open-chained intermediates ImA, ImBA, ImA3 were compared with the 
energies of their rotamers ImA’, ImBA’, ImA3’, respectively. In general, the rotamers, in 
which the aromatic carbon atom C-6 is more close to the sulfur atom, are slightly 
energetically favoured (by 0.8 kJ/mol - 2.1 kJ/mol). In addition, position 6 of the arene moiety 
has a higher electron density as compared to position 4. Based on these calculations, the sulfur 
atom of the S-Cl moiety is expected to preferentially attack at carbon C-6 (Table 3).  In 
addition, we computed the energies of the cationic cyclic intermediates ImA1, ImA1’, ImA2 
and ImA2’ (Table 4). Interestingly, intermediate ImA1 is considerably more stable than 
ImA1’ (by 16.15 kJ mol-1). Likewise, ImA2 is more stable than ImA2’ (by 12.63 kJ mol-1). 
The calculations rationalize the fact that isomer A instead of A’ is formed.  
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Table 3. Energies of the optimized structures, the energy differences between the conformers, 
natural (NBO) charges and distances (S-C) of ImA, ImA’, ImBA, ImBA’, ImA3, ImA3’ 
calculated at the B3LYP/6-31G* level for optimized structures. 
Intermediate ImA ImA’ ImBA ImBA’ ImA3 ImA3’ 
Energy / a.u. -
4167.66135 
4167.66105 -
3706.85652 
-
3706.85603 
-
3706.85263 
-
3706.85185 
ΔE /kJ mol-1 -0.785129 -1.28786 -2.06798 
Charge 
/a.u. 
C6 -0.21715 -0.19980 -0.19426  -0.19107 -0.20603 -0.18995 
C4 -0.20714 -0.22368 -0.19969  -0.20087 -0.19660 -0.20846 
S   0.33445   0.33571   0.33339   0.33321   0.31805   0.32131 
r (S-C)  
/ Å 
C6   3.33400   3.89695   3.24921   4.33132   3.20363   4.13341 
C4   3.87239   3.31937   4.35374   3.26222   4.17400   3.22313 
 
 
Table 4. Energies of the optimized structures, the energy differences between the conformers 
of ImA1, ImA1’, ImA2, ImA2’, A and A’ calculated at the B3LYP/6-31G* level for 
optimized structures. 
Intermediate ImA1 ImA1’ ImA2 ImA2’ A A’ 
Energy / a.u. -
3707.16569 
-
3707.15954 
-
3246.38173 
-
3246.37692 
-
3246.10058 
-
3246.09848 
ΔE /kJ mol-1 -16.15168 -12.6282 -5.5161 
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1.3 Conclusion 
Our findings are of particular importance for the future extension of work related to 
benzodithiophenes. The misinterpretation of the structures of many benzo[1,2-b;5,6-
b']dithiophenes by several authors is presumambly based on the fact that all of them relied on 
previously published reports without providing an independent unambiguous structural proof, 
such as an X-ray crystal structure analysis, 2D NMR or preparation of unsymmetrical 
derivatives. Our structural assignments are based on X-ray crystal structure analyses of the 
parent chlorinated dithiophenes and on NMR spectroscopic studies of unsymmetrical 
derivatives which were prepared for the first time. In addition, our desymmetrization 
approach can be explored under the optimized reaction, an absolute approach for structure and 
symmetry confirmation of such molecules. These findings provide clear basis to decide the 
symmery independently either if no any X-rays structure Would be  available. The formation 
of benzo[b]thiophenes starting from 3-phenylpropanoic acid with thionyl chloride and a small 
amount of pyridine was also mechanistically discussed by Krubsack et al. in 1975.7a Based 
on his investigations we carried out quantum chemical calculations for several possible 
mechanistic intermediates. The calculations support the experimental findings and indicate 
that the formation of 3,6-dichlorobenzo[1,2-b;5,6-b']dithiophenes is considerably more 
favored than the formation of 3,7-dichlorobenzo[1,2-b;4,5-b']dithiophenes. Our results are, of 
course, also important for the future design of related molecules and materials. 
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2. Synthesis of benzodithiazoles using N-benzyl DABCO tribromide (organic       
ammonium tribromide OATB) through oxidative cyclization of thiobenzanilides  
 
2.1 Introduction 
Heterocycles, in particular sulfur containing azoles, are valuable because of their important 
features as biologically active compounds, pharmaceuticals, and functional materials.10 Well-
known sulfur containing compounds include adrenergic receptor agonists, neuroprotective 
agents, antineoplastic agents, and electron-transporting materials. S. S. Kulkarni et al. have 
reported the essential pharmacophoric features of benzothiazole derivatives, such as 
metabotropic glutamate receptor-5 (mGluR5) antagonists which mediate actions of the 
excitatory neurotransmitter L-glutamate. Benzothiazole moieties are also found in a variety of 
biologically important natural products.11 They are used as active drugs for several diseases 
such as tumors, diabetes, Parkinson’s disease, tuberculosis, inflammatory diseases, epilepsy, 
viral infections, insomnia, and atherosclerosis.12 Also, they are inhibitors of several enzymes 
and function as antioxidants.13 Due to their vast importance, benzothiazole containing 
compounds are studied in detail during the recent couple of years.14 Significantly, fluorinated 
benzodithiazoles have been reported as new dyes used in both one and two photon 
fluorescence microscopy, demonstrating outstanding lysosomal selectivity.15 Benzodithiazoles 
with multiple functional groups can be novel ligands for their conversion with different metal 
salts to new metallorganic frameworks. Porous coordination polymers can be used as potential 
media for gas adsorption, gas separation and catalysis. The developments of efficient and 
economical methodologies for the functionalization of such heterocycles have received much 
attention in organic synthesis. Herein, the synthesis of new benzodithiazole derivatives 
through oxidative cyclization using N-benzyl DABCO tribromide has been discussed.  
  
2.2 Results and discussion 
Several conventional methods for the synthesis of different benzothiazole moieties are 
available in literature, like the condensation of 2-aminothiophenols with substituted nitriles, 
aldehydes, carboxylic acids, acid chlorides or esters.16 Intramolecular cyclization of N-(2-
halophenyl)benzothioamide is also reported for the synthesis of benzothiazoles. Hugerschoff 
found that aminobenzothiazoles can be synthesized from arylthioureas on reaction with liquid 
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bromine in chloroform.17 Despite good yields and low reaction times, several drawbacks are 
associated with the use of liquid bromine, which is a highly toxic, corrosive reagent. 
In recent years, investigations have shown that different benzothiazole derivatives can be 
synthesized efficiently through oxidative cyclization using organic ammonium tribromides 
(OATBs).18 Benzyltrimethylammonium tribromide, tetrabutylammonium tribromide and N-
benzyl-DABCO-tribromide can be used as alternative brominating reagents instead of liquid 
bromine. As compared to bromine, OATBs are crystalline solids, are capable of delivering a 
stoichiometric amount of bromine where small amounts of bromine are necessary for micro 
scale reactions (Figure 9).  Benzyltrimethyl ammonium tribromide has been successfully used 
for the conversion of substituted aryl thioureas to the corresponding 2-aminobenzothiazoles.19 
Herein in this chapter, the synthesis of various arylated benzodithiazoles with different 
substituents has been discussed. This method can be applied broadly to obtain arylated as well 
as alkylated benzodithiazoles efficiently (Scheme 4). 
 
H2N NH2
N
SS
N
R = CH3, F, Cl, H
Lawessons reagent
OATB, (1 : 2)
N
H
N
H
OO
RR
N
H
N
H
OO
RR
N
H
N
H
SS
RR
N
H
N
H
SS
RR
RRCH2Cl2 / CCl4
Toluene, reflux
ArCOCl, Et3N
CH2Cl2 , dry, 12h
7
9
9 10
10
11  
Scheme 4. Synthesis of 10a-f. Conditions: i, 7 (1.0 equiv.), Ar-COCl (2.0 equiv.), Et3N (4.0 
equiv), CH2Cl2, 0-20 °C, 10-12h; ii, 9 (1.0 equiv.), lawessons reagent (0.5 equiv), toluene, reflux at 
140 °C, 1-2h; iii, 10 (1.0 equiv), OATB (1.0 equiv. per cyclization), CH2Cl2/CCl4 (1:1, 10ml), 1-2h 
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Benzanilides were synthesized according to a previoisly reported method by reaction of 
commercially available 1,3-benzenediamine (7) with different benzoyl chlorides 8a-f under 
basic conditions.20 The diamides were transformed into thiobenzanilides 10a-f by refluxing 
with Lawesson's reagent (LR) in toluene for one hour.21 Lawesson's reagent has a four 
membered ring of alternating sulfur and phosphorus atoms. With heating, the central 
phosphorus/sulfur four-membered ring can open to form two reactive dithiophosphine ylides 
(R-PS2). Much of the chemistry of Lawessons's reagent is in fact the chemistry of these 
reactive intermediates. In general, the more electron rich a carbonyl is, the faster the carbonyl 
group will be converted into the corresponding thiocarbonyl compounds by Lawesson's 
reagent. Lawesson's reagent (Figure 8) is the most promising thionating agent giving high 
yields and minimum reaction times (Scheme 5).  
 
Figure 8. Lawesson's Reagent (LR) 
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Scheme 5. Thionation with Lawesson's Reagent (LR) 
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Table 3. Synthesis of thionated compounds 10a-f using Lawesson's Reagent (LR) 
9 Dibenzothioamide derivatives Time % (10)a 
a N,N'-(1,3-phenylene)bis(4-fluorobenzothioamide) 1h 82 
b N,N'-(1,3-phenylene)bis(4-chlorobenzothioamide) 1h 87 
c N,N'-(1,3-phenylene)bis(4-methylbenzothioamide) 1h 85 
d N,N'-(1,3-phenylene)dibenzothioamide 1h 90 
e N,N'-(1,3-phenylene)dipropanethioamide 1h 80 
f N,N'-(1,3-phenylene)bis(2,2-dimethylpropanethioamide) 1h 84 
              a Yields of isolated compounds 
Among different reported OATBs, especially N-benzyl-DABCO-tribromide gives high yields 
and the reactions proceed in short time.18 When thiobenzanilides 10a-f were dissolved in a 
mixture of dichloromethane and carbon tetrachloride (1:1) and treated with N-benzyl-
DABCO-tribromide (OATB), rapid and efficient oxidative cyclization to the corresponding 
benzodithiazole occured to give the corresponding products 11a-f in good yields 70-80% 
(Scheme 7).  
 
1) C6H5CH2Br (1.0 eq)
2) Br2 (1.0 eq),DioxaneN
N
Br3
N+
N
Ph  
Figure 9. N-Benzyl-DABCO tribromide (OATB) 
Scheme 6. Synthesis of N-benzyl-DABCO tribromide (OATB); conditions: DABCO (1.0 
equiv. in dioxane, 5 ml per 0.5 M), benzyl bromide (1.0 equiv. in dioxane, 5 ml), Br2 (1.0 
equiv in dioxane, 5 ml), 20 °C, 30 min 
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Thiobenzanilides on reaction with OATBs (one equiv. per thiocarbonyl group) cyclize to give 
the corresponding benzodithiazoles. The OATBs facilitate the easy going electrophilic 
bromination for efficient oxidative cyclization to give the resulting products (Figure 10). 
Moreover, it is also important to optimize the reaction conditions, like reaction time, 
temperature, and the solvent system. 
 
10
N
SS
N
RR
R = alkyl, aryl
OATB
N
H
N
H
R
S
R
S
CH2Cl2 / CCl4
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Scheme 7. Oxidative cyclization of benzodithiazole 
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Figure 10. Proposed mechanism for ring formation 
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Table 4. Synthesis of different benzodithiazoles using N-benzyl-DABCO-tribromide 
10 Benzodithiazoles Time (11)%a 
a 
N
SS
N
FF
 
90 min 72 
b 
N
SS
N
ClCl
 
60 min 67 
c 
N
SS
N
CH3H3C
 
40 min 75 
d 
N
SS
N  
40 min 70 
a Yields of isolated compounds 
I have also synthesized various alkylated benzodithiazole derivatives. The same procedures 
were applied successfully using different acyl chlorides R-COCl (Table 5). All the reactions 
were carried out in dichloromethane and carbon tetrachloride (1:1) to obtain highest yields. 
All compounds were characterized spectroscopic methods. 
 
Table 5. Synthesis of different benzodithiazoles 11 using N-benzyl-DABCO-tribromide 
10 Benzodithiazoles Time % (11)a 
e 
N
SS
N
C2H5C2H5
 
40 min 60 
f 
N
SS
N
C4H9C4H9
 
30 min 67 
a Yields of isolated compounds 
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2.3 Conclusion 
Herein, the synthesis of new benzodithiazoles from dithiobenzanilides through oxidative 
cyclization using N-benzyl DABCO tribromide has been described. N-Benzyl DABCO 
tribromide, being a crystalline solid, is safe to handle and provides high yields. It is a most 
efficient strategy and the reaction proceeds in short time under mild reaction conditions. Such 
benzodithiazol core structures can be the novel ligands to build-up new organic frameworks 
as porous coordination polymers which can be used as potenial media for gas adsorption, gas 
separation and catalysis. 
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3. Chemoselective Suzuki-Miyaura cross coupling reaction of 2-bromo-1-
(trifluoromethanesulfonyloxy)naphthalene,1-bromo-2-(trifluoromethanesulfonyl-
oxy)naphthalene and 2-acetyl-4-bromo-1-(trifluoromethanesulfonyloxy) naphthalene 
 
3.1 General Introduction  
The development of new, efficient and economical reactions for the formation of carbon-
carbon and carbon-heteroatom bonds have been studied as new methodologies for the 
formation of promising bioactive and valuable frames. These reactions very much facilitate 
the construction of complex molecules from simple precursors. The Grignard, Diels–Alder, 
and Wittig reaction have been of great use in this regard. Since the discovery of metal-
catalyzed cross-coupling reactions, a variety of metals have proven to be productive in 
organic synthesis. For the last three decades transition metal catalyzed reactions, particularly 
palladium(0)-catalyzed transformations, have gained remarkable importance for carbon-
carbon bond formation and many new ideas have been tested and realized.22 Nowadays, these 
reactions are being used for the synthesis of a number of natural products, pharmaceuticals 
and advanced materials.23-25   
 
3.1.2 Pd-catalyzed  reactions 
 
Since the discovery and continuing evolution of metal-catalyzed cross coupling reactions, 
palladium(0)-catalyzed carbon-carbon bond forming reactions provide a useful methodology, 
which has not only facilitated the synthesis of complex molecules but also served as an 
efficient route for the formation of carbon-carbon bonds used by synthetic chemists.23 
Palladium-catalyzed cross-coupling is used in research worldwide, as well as in commercial 
production of, for example, pharmaceuticals and molecules used in the electronic industry. 
The tool allows scientists to build complex chemicals such as the carbon-based ones that are 
the basis of life. This technique is applied in every field of chemistry, such as, total synthesis, 
nanotechnology, synthesis of advanced materials, medicinal and pharmacological chemistry. 
The most commonly applied palladium-catalyzed carbon–carbon bond forming reactions in 
total synthesis are, namely, the Heck26,27, Stille30, Suzuki28, Sonogashira29, Tsuji–Trost30, and 
the Negishi 31 reaction. The mechanisms of these reactions are similar. The first step is usually 
the oxidative addition of organic halides or triflates to the Pd(0) complex to form 
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organopalladium halides. The following step is, in case of the Suzuki, Sonogashira and Stille 
reaction, often a transmetallation with nucleophilic compounds to give a diorganopalladium 
complex. This complex undergoes a reductive elimination to create carbon-carbon bond and 
regeneration of the catalyst.  
 
R1 BY2 + R
2 X
cat. Pd
base
R1 R2
R1 = alkyl, aryl, vinyl
R2 = alkyl, alkynyl, vinyl, benzyl
X = Br, Cl, I, OTf , OTs
Suzuki Reaction
 
 
R1 H + R2 X R1
Sonogashira Reaction
cat. Pd
cat. CuX, base
R1 =alkyl, aryl, vinyl
R2 = aryl, benzyl, vinyl
X = Br, Cl, I, OTf  
 
R2R
3H
R1 R2
+ R4 X
R3R4
R1 R2
R4 = aryl, benzyl, vinyl
X = Cl, Br, I, OTf
cat. Pd
Heck Reaction
base
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Stile Reaction
R1 SnR3 + R2 X
cat. Pd
R1 R2
R1 = alkyl, alkynyl, aryl, vinyl
R2 = acyl, alkynyl, allyl, benzyl
X = Br, Cl, I, OTf , OAc  
 
R1 ZnR2 + R3 X R1 R3
R1 = alkyl, akynyl, aryl, vinyl
R3 = acyl, aryl, benzyl, vinyl
X = Br, I, OTf , OTs
Negishi Reaction
cat. Pd
 
 
X + NuH Nu
cat. Pd
base
X = Br, Cl,OCOR,
NuH = enamines, enolates
Tsuji-Trost Reaction
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3.1.3 Suzuki-Miyaura Cross-Coupling Reaction:  
The Suzuki-Miyaura coupling reaction has gained much importance for its usefulness for the 
cross-coupling between halides and organoboronic acids.32,33 Advances made in this field 
include the development of new catalysts and modern methods have greatly increased the 
scope of this reaction and is now considered to be a quite general procedure for a wide range 
of selective carbon-carbon bond formations.34,35 The scope of the reaction partners is not 
restricted to arenes, but includes also alkyl, alkenyl and alkynyl compounds. The mechanism 
of the Suzuki reaction involves the oxidative addition of organic halides or triflates to the 
Pd(0) complex to form a organopalladium halide (R1-PdII-X). This step is followed by 
transmetallation with a boronic acid derivative or a borane to give a diorganopalladium 
complex. This complex undergoes a reductive elimination with carbon-carbon bond formation 
and regeneration of the catalyst.35  
The palladium-catalyzed reactions had also been carried out with aryl bis(triflates). The 
palladium(0) catalyzed cross-coupling reaction of aryl triflates37 with aryl boronic acids in the 
presence of a base is a versatile method for preparing unsymmetrical substituted biaryls. The 
use of aryl triflates instead of aryl halides is particularly important in organic synthesis 
because it can provide a way of forming a carbon-carbon bond at a phenolic site, which is 
often useful when appropriate halides are unavailable.38 Since aryl triflates are easily available 
from the corresponding hydroxy compounds, the scope and applications of these compounds 
in transition metal catalyzed reactions has therefore attracted the interest of chemists. This 
coupling reaction offers the advantage of high yields, clean products with less side reactions, 
tolerance of a variety of functional groups on either coupling partner, and no necessity for 
anhydrous conditions. 
The reactivity order of aryl halides and aryl triflates, which act as electrophiles, is Ar-I > Ar-
Br > Ar-OTf > ArCl, where electronic and steric hindrance is also playing a role in 
selectivities. The use of base accelerates the transmetalation. This is due to the increase of the 
carbanion character of the organoborane moiety by formation of an organoborate containing a 
tetravalent boron atom. The selection of a proper catalyst plays an important role in the 
success of the desired reaction. The common palladium sources employed include, for 
example, Pd(OAc)2, PdCl2, Ph(PPh3)Cl2, and Pd(dba). The use of bulky electron-rich ligands 
is often the key for a successful transformation. Miyaura-Suzuki reactions37, in particular, are 
very attractive, due to the stability of the precursors, boronic acids, and facility of work up.  In 
this reaction even an alkyl group (i.e. sp3-hybridized C atom), as opposed to the more 
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traditionally used vinyl or aryl groups, can be transferred from the organoborane component 
during the palladium-catalyzed coupling process with vinyl or aryl halides or triflates. 
Compared to Stille reactions 39, Suzuki–Miyaura couplings have a much broader scope in that 
a potentially vast range of alkyl boranes (typically prepared through the regio- and 
chemoselective hydroboration of readily available alkene precursors) can be employed in the 
reaction.40 The interest of the chemist in this field is evident from the continuous 
developments in the use of new reaction conditions, catalysts and ligands.41-43 
 
3.2  Introduction 
Biaryl linkages, due to restricted rotation, often govern the biological activity of naphthalene 
natural products and are responsible to introduce atropisomerism. Anti-malarial and anti-HIV 
active naphthylisoquinolines, such as michellamine A, have attracted the scientific 
community.44-47 Resveratrol is a naturally occurring potent anticancer drug which, however, 
suffers from chemical and metabolic instability.48 To solve the problem, rigid and stable 
arylated naphthalenes were synthesized in which the stilbene double bond was substituted by 
a naphthalene ring. Among these compounds, some were found to be most active against 
human breast cancer cell line B. Konzik et. al. have shown that the phenyl substituents of 
naphthalenes have a strong influence on their fungistatic activity.49  
In recent years, regioselective palladium catalyzed reactions of polyhalogenated arenes or 
heteroarenes and of bis (triflates) have been widely studied.50 In general, the first attack 
occurs at the sterically less hindered and electronically most deficient position. Another 
strategy for the selective functionalization of arenes or heteroarenes relies on the 
chemoselectivity of substrates containing different leaving groups (e. g., triflate and bromide). 
Recent reports show that several parameters influence the chemoselectivity of Suzuki-
Miyaura reactions of arenes containing a bromide and a triflate group.51 While various 
palladium catalyzed cross coupling reactions of naphthalene derivatives have been reported,47 
regio- and chemoselective transformations of naphthalenes containing two or more reactive 
sites, such as bromide or triflate groups, have only scarcely been studied so far. 
In this chapter, the steric and electronic effect on chemoselective Suzuki-Miyaura coupling 
reactions has been described using 2-bromo-1-(trifluoromethane-sulfonyloxy)naphthalene 15, 
1-bromo-2-(trifluoromethane-sulfonyloxy)naphthalene 22 and 2-acetyl-4-bromo-1-
(trifluoromethanesulfonyloxy)naphthalene 27. All these reactions proceed with excellent 
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chemoselectivity and provide a convenient approach to various arylated naphthalene 
derivatives which are not readily available by other methods. 
 
3.3 Results and discussion 
In 2005, Bekaert et. al. described52 the selective synthesis of 2-bromonaphth-1-ol (13) by 
reaction of 1-tetralone (12) with N-methylpyrrolidin-2-one hydrotribromide (MPHT, 
[NMP]2HBr3). An alternative approach to 13 was found which is based on the bromination53 
of 12 using NBS (2.2 equiv.) and (PhCOO)2, 5 mol %) (Scheme 8). Inexpensive reagents and 
good yield (84 %) are the benefit of this method. It is notable that, although free radical 
conditions were applied, bromination at position 4 was not observed. The same bromination 
methodology provided other required halogenated naphthalenes. Later on 2-bromonaphth-1-ol 
13 was transformed to its triflate 15 in very good yield (Scheme 8).  
 
O OH
Br
3.eq.NBS,DBPO
C6H6,reflux, 4h
OH
Br
Br (84%)(10%)
4.eq.NBS,DBPO
C6H6,reflux, 4h
Et3N, 1.eqEt3N, 1.eq
+
OH
Br
(84%)
O OH
Br
(84%)
i
OTf
Br
(92%)
ii
12 13
15
14
12 13
 
Scheme 8. Synthesis of 13 and 15. Conditions: i, 12 (1.0 equiv.), NBS (2.2 equiv.), (PhCOO)2 
(5 mol %), benzene, reflux, 5h; ii, 13 (1.0 equiv), Tf2O (1.2 equiv), pyridine (2.0 equiv), 
CH2Cl2, 20 °C, 12h 
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Figure 11: Important HMBC (single pointed arrow), NOESY (dashed arrow) and COSY 
(double pointed arrow) correlations of 13 
The bromine position was determined by 2D NMR correlation techniques (HMBC and 
NOESY). A clear correlation was found to assign the relative bromination position (Figure 
11). In HMBC and NOESY plots of compound 13, C-4 proton is showing a clear interaction 
with C-3 as well as C-5 proton to confirm the mono bromination. However, by increasing the 
amount of NBS up to 4.0 equiv., further bomination was observed at C-4 to obtain 2,4-
dibromonaphthalen-1-ol 14 along with compound 13. 2,4-Dibromonaphthalen-1-ol was 
obtained in very small amount (10 %) and further addition of NBS along with changing other 
parameters could not make a difference to increase their yield. 
The S-M reaction of 15 with arylboronic acids 16a,c-f (1.0 equiv.) afforded the 2-arylnaphth-
1-yl trifluoromethanesulfonates 17a-e in 60-88 % yields (Scheme 9, Table 6). The reactions 
proceeded with very good chemoselectivity in favour of the bromide position, while the 
triflate remained unattacked. Aryl bromides generally undergo Suzuki-Miyaura reactions 
faster than aryl triflates.51 This reactivity order is different for other palladium catalyzed 
cross-coupling reactions. One of the justifications for that is based on the high borane-halide 
affinity. Nevertheless, other parameters control the selectivity as well. During the 
optimization, significance to use exactly equimolar quantities of the arylboronic acid was 
established and Pd(PPh3)4 (5 mol %) as the catalyst. The temperature played an imperative 
role as well. A good selectivity was attained only when the reaction was carried out at 90 °C 
(instead of 110 °C) because the reaction of the triflate was slow at this temperature. The 
reactions were successful for both electron-rich and electron-poor arylboronic acids, but again 
electron-poor boronic acids provided better yields.  
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OTf
Br
15
OTf
Ar1
17a-e
i
Ar1 B(OH)2
16a,c-f
 
Scheme 9. Synthesis of 17a-e. Conditions: i, 15 (1.0 equiv.), Ar1B(OH)2 (1.0 equiv.), 
Pd(PPh3)4 (5 mol %), K3PO4 (1.5 equiv.), dioxane, 90 °C,  4h. 
 
Figure 12: Ortep plot of 17e 
 
       Table 6. Synthesis of 17a-e 
15 16 Ar % (17)a 
a a 2-(MeO)C6H4 60 
c b 4-MeC6H4 73 
f c C6H5 77 
d d 4-ClC6H4 88 
e e 4-FC6H4 85 
a Yields of isolated compounds 
The Suzuki-Miyaura coupling reaction of 17a-e with arylboronic acids 16a,f-i (1.1 equiv.) 
afforded the unsymmetrical 1,2-diarylnaphthalenes 18a-e containing two different aryl groups 
(Scheme 10, Table 7). The reactions were carried out at 110 °C. The application of a one-pot 
synthesis of products 18 by sequential addition of two different arylboronic acids resulted in a 
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decrease of the yield (with respect to the stepwise protocol). Therefore, this strategy was not 
further studied. 
Ar2B(OH)2
16a,f-i
Ar2
Ar1
18a-e
i
OTf
Ar1
17a-e  
Scheme 10. Synthesis of 18a-e. Conditions: i, 17a-e (1.0 equiv.), Ar2B(OH)2 (1.1 equiv.), 
Pd(PPh3)4 (5 mol %), K3PO4 (1.5 equiv.), dioxane, 110 °C,  4 h 
 
Figure 13: Ortep plot of 18d 
   Table 7. Synthesis of 18a-e 
18 16 17 Ar1 Ar2 % (18)a 
a f a 2-(MeO)C6H4 4-tBuC6H4 80 
b g b 4-MeC6H4 2,5-(MeO)2C6H3 65 
c a c C6H5 2-(MeO)C6H4 69 
d b d 4-ClC6H4 3,5-Me2C6H3 72 
e i e 4-FC6H4 3-MeC6H4 77 
a Yields of isolated compounds 
The Suzuki-Miyaura (S-M) coupling reaction of 15 with arylboronic acids 16a-c (2.2 equiv.) 
provided the symmetrical 1,2-diarylnaphthalenes 19a-c in 62-94 % yield (Scheme 11, Table 
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8).33 Both electron-poor and electron-rich arylboronic acids could be successfully employed. 
Better yields were observed with electron-poor arylboronic acids as compared to electron-rich 
arylboronic acids. The best yields were obtained using Pd(PPh3)4 (5 mol %) as the catalyst and 
K3PO4 (3.0 equiv.) as the base. 1,4-Dioxane was used as solvent and reactions were carried 
out at 110 C.  
OTf
Br
15
Ar
Ar
19a-c
i
ArB(OH)2
16a-c
 
Scheme 11. Synthesis of 19a-c. Conditions: i, 15 (1.0 equiv.), ArB(OH)2 (2.2 equiv.), 
Pd(PPh3)4 (5 mol %), K3PO4 (3.0 equiv.), dioxane, 110 °C,  4 h 
Table 8. Synthesis of 1,2-diarylnaphthalenes 19a-c 
16,19 Ar % (19)a 
a 2-(MeO)C6H4 62 
b 4-MeC6H4 79 
c 4-ClC6H4 94 
a Yields of isolated compounds 
 
Figure 14. Ortep plot of  19c 
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Structures of all compounds were established by NMR spectroscopy whereas structures of 
19b and 19c were also confirmed independently by X-ray crystallography (Figure 15).  
 
 
Figure 15: Ortep plot of 19b. 
To figure out whether the stronger steric hindrance of position 1 plays a role in the selectivity, 
1-bromonaphthalen-2-yl trifluoromethanesulfonate (22) was also studied. The bromine and 
OTf group position were exchanged in compound 22 having bromine at C-1 along with the 
hydroxy group at C-2. Compound 22 was prepared from 2-tetralone (20) using NBS (3 
equiv.). Subsequent triflation of 21 provided 22 (Scheme 12). 
 
Br
OHO
20 21
Br
OTfi i i
22  
Scheme 12. Reaction conditions: i, 20 (1.0 equiv.), NBS (3 equiv.), (PhCOO)2 (5 mol %), 
benzene, reflux, 5 h; ii, 21 (1.0 eq), Tf2O (1.2 equiv.), pyridine (2.0 equiv.), CH2Cl2, 20 °C, 
6h.  
Interestingly, the S-M reaction of 22 with arylboronic acids 16a,b (1.0 equiv.) afforded the 1-
arylnaphth-2-yl trifluoromethanesulfonates 23a,b in 60-73 % yields (Scheme 13, Table 9).  
This proves that the bromine-halide affinity possesses a decisive role in the selectivity of S-M 
reactions of compounds 15 and 22, because in all case C-Br is attacked preferably.  
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Br
OTf
Ar
OTf
i
ArB(OH)2
22 23a-b  
Scheme 13. Synthesis of 23a-b. Conditions: i, 22 (1.0 equiv.), ArB(OH)2 (1.0 equiv.), 
Pd(PPh3)4 (5 mol %), K3PO4 (1.5 equiv.), dioxane, 90 °C,  4h 
 
       Table 9. Synthesis of 23a-b 
23 16 Ar1 % (23)a 
A a 4-MeC6H4 60 
B b (2-MeO)-5-ClC6H3 73 
a Yields of isolated compounds 
 
OPh
O
OTf
OTf OOTf
carbon C-2
more sterically hindered
OMe
carbon C-5
less sterically hindered
OTf
carbon C-1
more sterically hindered
more electron-def icient
carbon C-4
less sterically hindered
less electron def icient
2
2
1
1
1 2
3
4
123
4 5
 
 
Figure 16. Previously reported site-selective S-M cross coupling reaction of phenyl 1,4-
bis(trifluoromethylsulfonyloxy)-2-naphthoate 
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The previous results of regioselective S-M arylation of phenyl 1,4-
bis(trifluoromethylsulfonyloxy)-2-naphthoate (Figure 16) show that the first attack occurs at 
the more electron deficient and sterically hindered position C-1.54  In fact, the oxidative 
addition of the electron-rich palladium species usually occurs first at the most electron 
deficient carbon atom. As a consequence, the result of chemoselective S-M reactions of 2-
acetyl-4-bromonaphthalen-1-yl trifluoromethanesulfonate 27 is of great interest (Figure 18). 
OOTf
Br
OOH
OO
OOH
Br
+
87%
11%
92%
3.eq.NBS, (PhOO)2
1.2 eq.Tf2O, pyridine
24
25
26
27
i
i i
 
Scheme. 14 Reaction Conditions: i,  24 (1.0 equiv.), NBS (3.0 equiv.), (PhCOO)2 (5 mol %), 
benzene, reflux, 4h; ii, 25 (1.0 equiv.),  Tf2O (1.2 equiv.), pyridine (2.0 equiv.), CH2Cl2, 20 
°C, 6h.  
 
Figure 17: Ortep plot of 25. 
2-Acetyl-3,4-dihydronaphthalen-1(2H)-one 24 is a commercially available substrate and was 
successfully brominated using NBS (3.0 equiv.) and (PhCOO)2 (5 mol %) (Scheme 14) to 
give a separable mixture of products 25 (82 %) and 26 (11 %). 1-(4-Bromo-1-
hydroxynaphthalen-2-yl)ethanone (25) was transformed to its corresponding triflate 27 in 
high yield (Scheme 14). The bromination at C-4 was decided on the basis of X-ray analysis 
(Figure 17). 
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OOTf
Br
OOTf
Ar
OAr
Ar
ArB(OH)2 (1.0 equiv.)
ArB(OH)2 16c,l
27 28
29
16c,j
i
i i
(2.2 equiv.)
 
Scheme 15. Synthesis of 28a,b and 29a,b. Conditions: i, 27 (1.0 equiv.), Ar1B(OH)2 (1.0 
equiv.), Pd(PPh3)4 (5 mol %), K3PO4 (1.5 equiv.), dioxane, 90 °C,  4h; ii, 27 (1.0 equiv.), 
ArB(OH)2 (2.2 equiv.), Pd(PPh3)4 (5 mol %), K3PO4 (3.0 equiv.), dioxane, 110 °C,  4h.  
O
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1 27
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Figure 18. Chemoselective S-M coupling reaction of 2-acetyl-4-bromonaphthalen-1-yl 
trifluoromethanesulfonate 27 
It was expected that the electronic effect may dominate the first attack at C-1 being the 
electron deficient carbon as compared to C-4. Fascinatingly, the S-M reaction of 27 with 
arylboronic acids 16c,j (1.0 equiv.) provided the 4-aryl-2-acetylnaphthalen-1-yl 
trifluoromethanesulfonates 28a-b in 62-79 % yields (Scheme 15, Table 10). The reactions 
proceeded with chemoselectivity in favour of the bromide position, while the C-1 triflate 
remained unattacked even though being more electron deficient. This S-M cross-coupling 
42 
 
order is reverse to the regioselectivity as our group reported before for phenyl 1,4-
bis(trifluoromethylsulfonyloxy)-2-naphthoate.54 
 
     Table 10. Synthesis of 27a-b 
25 16 Ar % (27)a 
a j 4-(MeO)C6H4 62 
b c 4-ClC6H4 79 
a Yields of isolated compounds 
 
OOTf
OCH3
HH
H
H
H
H
H
HH
 
 
Figure 19: Important HMBC (single headed arrows), NOESY (dashed arrows) and 
COSY (double headed arrows) correlations of 27a. 
The structure of 27a was elucidated by detailed 2D NMR techniques. HMBC and NOESY 
plots show characteristic correlations to establish the exact assignment of 27a (Figure 19). 
Protons located at the naphthalene ring at position 3 and 5 show clear interations with protons 
of the benzene ring.  
Likewise, the S-M reaction of 27 with arylboronic acids 16b-c (2.2 equiv.) afforded the 1,2-
diarylnaphthalenes 29b,c in 62-79 % yield (Scheme 15, Table 11). 
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   Table 11. Synthesis of 21a-b 
27 16 Ar % (29)a 
A b 4-MeC6H4 62 
b c 4-ClC6H4 79 
a Yields of isolated compounds 
 
3.4 Conclusion 
In conclusion, I have reported the chemoselective Suzuki-Miyaura reactions of 2-bromo-1-
(trifluoromethanesulfonyloxy)naphthalene 15, 1-bromo-2-(trifluoromethanesulfonyloxy) 
naphthalene 22 and 2-acetyl-4-bromonaphthalen-1-yl trifluoromethanesulfonate 27 to achieve 
symmetrical and unsymmetrical naphthalene derivatives. I have studied the effect of steric 
hindrance and of electronic induction on chemoselective arylation at Br versus OTf; whatever 
the case, in all these three substrates we provide unambiguous evidence that the first attack is 
always observed selectively at brominated carbon (C-Br) while C-OTf was attacked later on.  
The strategy outlined herein provides a convenient approach to 1,2-diarylnaphthalenes and 2-
acetyl 1,4-diarylnaphthalenes products which are not readily available by other methods. 
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4. Synthesis of heteroaryl-fused benzopyranone analogues and arylated 
naphthaquinones  via palladium-catalysed Suzuki-Miyaura coupling reactions 
 
4.1 Introduction 
Sulphur containing heterocycles paved the way for the active research in the pharmaceutical 
chemistry. Benzothiophene derivatives in combination with other ring systems have been 
used extensively in pharmaceutical applications.55 Raloxifene, a drug based on benzo[b]- 
thiophene, has been approved by the U.S Food and Drug Administration for the prevention 
and treatment of osteoporosis associated with woman post menopausal.56,57 
Benzo[b]thiophene containing molecules, in particular 2,3-diarylbenzo[b]thiophenes and their 
3-carbonyl-or hetero atom-inserted analogues, are known to work as selective estrogen 
receptor modulators.58 Recently, some benzothiophene derivatives, like methyl 2,3'-
bibenzo[b]thiophene-2'-carboxylate and other analogues of its pharmaceutically acceptable 
salts as 3-(6-hydroxynaphthalen-2-yl)benzothiophene-2-carboxylic acid, have been reported 
to be the biologically most active drugs for the treatment of protein folding disorder, such as 
Alzheimer's disease, dementia, Parkinson's disease, Huntington's disease.59 On the other hand, 
multiply arylated benzothiophenes have also been considered interesting in the field of 
electronics.60  In fact polysubstituted benzothiophene compounds are playing an important 
role in the chemical and pharmaceutical industries as well as in the fields of optical and 
electronic materials. Optically most interesting dibenzodithiophenes and 
tetrabenzodithiophenes show characteristic photoluminescence spectral properties. Therefore, 
the synthesis of these arylated-benzothiophenes is of considerable importance in organic 
synthesis. 
 
4.1 .1 Results and discussion 
 
Kodumuru and coworkers have reported microwave promoted parallel syntheses of 
benzothiophenes, but this method has several limitations with regard to yields, and synthetic 
steps, and availability of the starting materials.61 Herein, I have described the synthesis of 
various heteroaryl-fused benzopyranone analogues and other 3-arylated benzothiophenes. 
Methyl 3-bromobenzo[b]thiophene-2-carboxylate 33 was obtained using o-nitrobenzonitrile 
according to the literature methods (Scheme 16). 62,63 The Suzuki-Miyaura (S-M) reaction of 
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33 with arylboronic acids 34a-h (1.2 equiv.) provided the 3-aryl-2-
methoxycarbonylbenzo[b]thiophenes 35a-h in good yield (Scheme 17, Table 12). Both 
electron-poor and electron-rich arylboronic acids were successfully employed. The best yields 
were obtained using Pd(PPh3)4 (5 mol %) as the catalyst and K3PO4 (1.5 equiv.) as the base. 
1,4-Dioxane was used as solvent and reactions were carried out at 90 C.  
CN
NO2
32
S
NH2
O
OCH3 S
Br
O
OCH3
33
i ii
O OCH3
HS
+
31  
 
Scheme 17. Synthesis of 32 and 33. Conditions: i, 31 (1.0 equiv.), methyl thioglycolate (1.0 
equiv.), KOH, DMF,  0 °C, 1h; ii, 32, tert-butyl-nitrite, CuCl2, CH3CN,  0 °C, 2 h,  20 % aq HCl.  
S
Br
O
OCH3 S
O
OCH3
R
33 35 a-h
i
Ar-B(OH)2
R = CH3,OCH3, X, H  
Scheme 18. Synthesis of 35a-g. Conditions:  i, 33 (1.0 equiv.), ArB(OH)2 (1.2 equiv.), Pd(PPh3)4 
(5 mol %), K3PO4 (1.5 equiv.), dioxane, 90 °C,  4h. 
             Table 12. Synthesis of 35a-g 
33 Ar 35% Yield a 
A C6H5 88 
B 4-ClC6H4 71 
C 4-MeC6H4 79 
D 4-(CF3)C6H4 68 
E 2-(MeO)C6H4 86 
F 2,6-(MeO)2C6H3 74 
G 5-Cl-2-(MeO)C6H3 70 
H 1-Naphthyl 84 
a Yields of isolated compounds 
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Scheme 19. Conditions:  i, 35 (1.0 equiv.), H2SO4 
 
Compounds 35a-e were treated with H2SO4 to obtain the expected cyclized products, 2H-
benzo[b]indeno[1,2-d]thiophen-2-ones. But this reaction failed, probably due to high ring 
strain in molecule. However, the Suzuki-Miyaura (S-M) reaction of 33 with o-methoxyphenyl 
boronic acids 34e,g  gave compounds 35e-g which were transformed by BBr3 mediated 
lactonization, according to literature methods,64 to 36a,b in 74-80 % overall yields (Scheme 
19). Borontribromide was used for the demethylation process, followed by a 0.1 M solution of 
(CH3)3COK as a base for the lactonization (Table 13).   
 
S
COOCH3
35 e,g
S
O
O
36 a,b
iOCH3
 
Scheme 20. Synthesis of 36a,b; Conditions: i, 35 (1.0 equiv.), BBr3 (4.0 equiv.), 0 °C, 2h,     
(ii) (CH3)3COK, (0.1 M, aq), 20 °C, 1h  
 
          Table 13. Synthesis of 36a,b 
33 Ar 36% Yield a 
E 2-(MeO)C6H4 74 
G 5-Cl-2-(MeO)C6H3 80 
a Yields of isolated compounds 
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Figure 22: Ortep plot of 36a  
The structures were established by 1D and 2D NMR experiments (NOESY, HMBC), whereas 
the structure of 36a was confirmed independently by X-ray crystallography (Figure 22). 
 
In conclusion, various analogues of 6H-[1]benzothieno[2,3-C]chromen-6-ones  and 3-aryl-2-
methoxycarbonylbenzo[b]thiophenes  were synthesized through Suzuki-Miyaura reactions. 
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4.2 Synthesis and optimization of 2,3-diaryl-1,4-naphthoquinones and 2-aryl-1,4-
naphthoquinones through S-M cross coupling reactions  
 
4.2.1 Intoduction 
Highly substituted derivatives around fused aromatic cores are of particular interest due to 
their stability, solubility, enhanced ability to transport charge, and fluorescent properties in the 
solid state.65 The biaryl linkage, due to its restricted rotation, governs the biological activity of 
naphthalene natural products and is responsible to introduce atropisomerism. Due to anti-
malarial and anti-HIV activity, naphthylisoquinolines, such as the michellamines, have 
attracted the scientific community.66,67 Resveratrol is a naturally occurring potent anticancer 
drug which, however, suffers from chemical and metabolic instability.68 In connection to our 
earlier work on chemoselective arylation,53 we were interested in the synthesis of 1,2,3,4-
tetrarylnaphthalene derivatives. In the literature, several synthetic approaches to such 
phenylnaphthalenes have been described.69  
 
4.2.2 Results and Discussion  
In recent years, chemo- and regioselective palladium catalyzed reactions of polyhalogenated 
arenes or heteroarenes and of bis(triflates) have been widely studied.71 Recent reports show 
that several parameters influence the chemoselectivity of Suzuki-Miyaura reactions of arenes 
containing a bromide and a triflate group.53 While various palladium catalyzed cross coupling 
reactions of naphthalene derivatives have been reported, regio- and chemoselective 
transformations of naphthalenes containing two or more reactive sites, such as bromide or 
triflate groups, have only scarcely been studied so far (Figure 24).  
OTf
OTf
Br
Br
 
Figure 24. Our synthetic approach 
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2,3-Dibromonaphthalene-1,4-diol 38 was synthesized from inexpensive commercially 
available 2,3-dibromo-1,4-naphthaquinone 37 on treatment with aqueous sodium dithionite 
Na2S2O4 in high yield (90 %).72 Later on, 37 was transformed to give their corresponding 2,3-
dibromonaphthalene-1,4-diylbis(trifluoromethanesulfonates) 39 (Scheme 21, Figure 25). 
 
O OH
Br
i
OTf
Br
i i
O
Br
Br Br
OH
Br
OTf
Na2S2O4
37 38
39  
Scheme 21. Synthesis of 38 and 39. Conditions: i, 38 (1.0 equiv.), Na2S2O4 (aq), 1h; ii, 39 (1.0 
equiv.), Tf2O (2.2 equiv.), pyridine (2.0 equiv.), CH2Cl2, 20 °C, 8h   
 
Figure 25. Ortep plot of 39  
The X-ray structure shows that both OTf groups are twisted out of plane (Figure 25). The 
Suzuki-Miyaura (S-M) reactions of 39 (1.0 equiv.) with arylboronic acids Ar B(OH)2 40a-e 
(2.0-6.0 equiv.), using Pd(PPh3)4 (5 mol %), K3PO4 (2.0-8.0 equiv.), 1,4-dioxane (90-130 °C,  
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4-6h), were expected to give the tetra-arylated naphthalenes (Figure 24). However, the 
arylation occurred only at the bromine positions to give 2,3-diphenylnaphthalene-1,4-diones 
41a-e by coupling, hydrolysis of the triflate and oxidation (Scheme 22). 
OTf
OTf
Br
O
O
Br
39
41
R
R
R = CH3, OCH3, X, H
 
Scheme 22. Synthesis of 41a-g. Conditions:  i, 39 (1.0 equiv.), Ar B(OH)2 (6.0 equiv.), 
Pd(PPh3)4 (10 mol %), K3PO4 (8.0 equiv.), dioxane, 90-140 °C,  4-8 h.  
    
I have tried different parameters to obtain tetra-arylated products. During the optimization, 
several important factors were considered which may effect the carcon-carbon coupling 
reaction: (i) use of the arylboronic acids in excess; (ii) both electron-poor and electron-rich 
arylboronic acids were used; (iii) temperature; (iv) reaction time; (v) bases: K3PO4, KF, 
Cs2CO3; (vi) hydrolysis of the triflate was prevented by application of non-aqueous 
conditions; (vii) solvent; (viii) choice of palladium catalysts: Pd(PPh3)4, Pd(OAc)2, 
Ph(PPh3)Cl2, and Pd(dba);  (vix) mol percentage of catalyst (5-20 mol %). Unfortunately, all 
attemptes were unsuccessful. 
                 Table 14. Synthesis of  41a-f 
41 Ar % (41)a 
A 2-(MeO)C6H4 70 
B 4-(MeO)C6H4 74 
c 4-MeC6H4 82 
d 2-ClC6H4 87 
e C6H5 84 
a Yields of isolated compounds 
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Figure 26. Ortep plot of 41c 
I have also studied 2-bromonaphthalene-1,4-diyl-bis(trifluoromethanesulfonate) 44 for Suzuki 
reactions (Scheme 23). The starting material 43 was prepared according to the literature.72  
O OH
Br
i
OTf
Br
i i
O
Br
OH
OTf
Na2S2O4
42 43
44  
Scheme 23. Synthesis of 43. Conditions: i, 41 (1.0 equiv.), Na2S2O4 (aq), 1h; ii, 42 (1.0 equiv.), Tf2O 
(2.2 equiv.), pyridine (2.0 equiv.), CH2Cl2, 20 °C, 8h 
 
Similar results as for 41 were obtained for the Suzuki-Miyaura cross coupling reactions of 44 
with arylboronic acids (4.0 equiv.). The 2-phenylnaphthalene-1,4-diones 45a,b were formed 
by coupling, hydrolysis and oxidation (Scheme 24). 
OTf
OTf
Br
O
O44 45
R
i
 
Scheme 24. Synthesis of 45a,b. Conditions: i, 44 (1.0 equiv.), ArB(OH)2 (4.0 equiv.), Pd(PPh3)4 (5 
mol %), K3PO4 (6.0 equiv.), dioxane, 90-120 °C,  4-8 h 
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                 Table 15. Synthesis of 45 
44 Ar % (45)a 
a 2-(MeO)C6H4 70 
b 4-(Meo)C6H4 74 
a Yields of isolated compounds 
 
4.3 Conclusions 
In summary, the synthesis of different benzopyranone analogues and arylnaphthaquinones via 
palladium-catalysed Suzuki-Miyaura coupling reactions has been discribed. Finding a simple 
method, benzothiophene and naphthaquinone frameworks have been synthesized which can 
be of considerable pharmacological relevance.  In addition, the palladium-catalysed cross 
coupling reaction of 2,3-dibromonaphthalene-1,4-diylbis(trifluoromethanesulfonate) 39 and 
2-bromonaphthalene-1,4-diyl bis(trifluoromethanesulfonate) 44 with boronic acids are not 
tolerable under any conditions and always resulted to give 2,3-diphenylnaphthalene-1,4-
diones 41 and 45.  
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Kurze Zusammenfassung der Dissertation 
Diese Dissertation behandelt die Untersuchung verschiedener synthetischer Heterocyclen, 
insbesonders Benzodithiophene, Benzothiazole und Benzopyranone. Wir haben die Ablaeufe für diese 
oxidativen Reaktionen und deren cyclisierungs Muster umfassend untersucht. Darüber hinaus ist die 
chemoselektive Kreuzkupplung fuer Reaktionen von Brom und Triflat, unter Verwendung von Pd(0) 
als Katalysator, auch im Detail beschrieben. Außerdem werden die insgesammten sterischen und 
elektronischen Effekte chemoselektiver Kreuzkupplungsreaktionen von Benzothiophenen, 
Naphthalinen und Naphthochinonen vorgestellt. 
 
Short Summary  
This thesis deals with the synthetic studies of different heterocycles like benzodithiophenes, 
benzodithiazoles and benzopyranones. We have examined a comprehensive protocol for such 
oxidative reactions and their cyclization pattern. In addition, Pd(0) catalyzed chemoselective cross 
coupling reactions of bromine versus triflate are also described in more detail. Herein, the overall 
steric and electronic effects on chemoselective cross coupling reactions of benzothiophenes, 
naphthalenes, Naphthaquinones are presented.  
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Experimental Section 
 
5 Materials and Methods 
 
5.1 General Remarks 
 
Reactions were carried out under inert atmosphere (Argon 4.6) in order to simultaneously 
exclude oxygen and water when appropriate. Pressure tubes were used to avoid condenser. 
Solvents for reactions were dried and distilled by standard methods or purchased from Merck, 
Aldrich, Acros Organics, and others whenever exclusion of water was desired. Solvents for 
liquid chromatography and extraction were always distilled prior to use and partly reused after 
fractional distillation (n-heptane, ethyl acetate). 
 
5.2.1 Methods for Compound Characterization and Analysis  
 
NMR Spectroscopy  
Bruker AC 250, Bruker ARX 300, Bruker ARX 500. For NMR characterization the one-
dimensional 1H NMR, proton-decoupled 13C NMR, and DEPT 135 spectra were collected. If 
necessary, other techniques (NOESY, COSY, HMQC, HMBC) were applied as well. All 
NMR spectra presented in this work were collected in CDCl3 solution. All chemical shifts are 
given in ppm.  
References (1H NMR): TMS (δ = 0.00) or residual CHCl3 (δ = 7.26) were taken as internal 
standard.  
References (13C NMR): TMS (δ = 0.0) or residual CHCl3 (δ = 77.0) were taken as internal 
standard.  
Multiplicities are given as follows: s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet, br = broad signal. More complex coupling patterns are represented by combinations 
of the respective symbols. For example, td indicates a triplet of doublets with the larger 
coupling constant associated with the first symbol (here: triplet).  
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Infrared Spectroscopy (IR)  
Nicolet 205 FT-IR, Nicolet Protége 460 FT-IR. Peaks are given the following assignments: w 
= weak, m = medium, s = strong, br = broad.  
 
Mass Spektrometry (MS)  
AMD MS40, Varian MAT CH 7, MAT 731 (EI, 70 eV), Intecta AMD 402 (EI, 70 eV and 
CI), Finnigan MAT 95 (CI, 200 eV).  
 
High Resolution Mass Spectrometry (HRMS)  
Varian MAT 311, Intecta AMD 402.  
 
Elemental Analysis  
LECO CHNS-932, Thermoquest Flash EA 1112.  
 
Melting Points  
Micro heating table HMK 67/1825 Kuestner (Büchi Apparatus), Leitz Labolux 12 Pol with 
heating table Mettler FP 90. Melting points are uncorrected.  
 
X-ray Structures 
Bruker X8Apex diffractometer with CCD camera (Mo Kα radiation and graphite 
monochromator, λ = 0.71073 Å). The space group is determined by the XPREP program and 
the structures were solved via the SHELX-97 program package. Refinements were carried out 
according to the minimum square error method.  
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5.2    Chromatographic Methods  
 
Thin Layer Chromatography (TLC)  
Merck Kieselgel 60 F254 on aluminium foil from Macherey-Nagel. Detection was carried out 
under UV light at 254 nm and 365 nm. As colourizing reagent the following mixtures were 
used: 1-2/100 p-Anisaldehyde or vanillin, 10/100 glacial acetic acid, 5/100 sulphuric acid, 83-
84/100 methanol.  
 
Column Chromatography  
Column chromatography was performed with Merck Silica Gel 60 or Macherey-Nagel Silica 
Gel 60 (0.063-0.200 mm, 70-230 mesh). The finer Merck Silica Gel 60 (0.040-0.063 mm, 
230-400 mesh) was chosen when appropriate.  
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6 General Procedures  
 
6.1 Synthesis of Benzo[1,2-b;5,6-b']dithiophenes and their Subsequent unsymmetrical 
derivatives through Suzuki-Miyaura Reaction 
6.1.1  2,7-Bis(methoxycarbonyl)-3,6-dichlorobenzo[1,2-b;5,6-b']dithiophene (2): 
 
General procedure A for the synthesis of 2. Thionyl chloride (6 ml, 80 mmol) was added 
portionwise to a mixture of 1,4-phenylene-diacrylic acid (2.00 g, 9.16 mmol) and of a 
catalytic amount of pyridine (0.2 ml). The reaction mixture was heated for 5 h at 140 °C. 
Upon cooling, the product solidified and the excess of thionyl chloride was removed under 
reduced pressure to give a greenish solid. This solid was dissolved in 50 ml of benzene and to 
the solution 10 ml of methanol was added. The mixture was heated at reflux for 2 h to give a 
crude product 2.  
 
6.1.2 2,7-Bis(butoxycarbonyl)-3,6-dichlorobenzo[1,2-b;5,6-b']dithiophene (3): 
 
General procedure A for the synthesis of  (3): 
Thionyl chloride (6 ml, 80 mmol) was added portionwise to a mixture of 1,4-phenylene-
diacrylic acid (2.00 g, 9.16 mmol) and of a catalytic amount of pyridine (0.2 ml). The reaction 
mixture was heated for 5 h at 140 °C. Upon cooling, the product solidified and the excess of 
thionyl chloride was removed under reduced pressure to give a greenish solid. This solid was 
dissolved in 50 ml of benzene and to the solution 10 ml of n-butanol was added. The mixture 
was heated at reflux for 2 h to give the crude product of butyl ester 3. The residue was 
purified by flash column chromatography (silica gel, heptanes / ethyl acetate = 9:1). The 
spectroscopic data of compound 3 were identical with those reported in the literature.  
 
General procedure B for Suzuki–Miyaura reactions: A 1,4-dioxane solution (5 ml) of K3PO4 
(2.0 equiv.), Pd(PPh3)4 (5 mol%) and arylboronic acids (1.2 equiv.) was stirred at 110-120 °C 
for 4 h. After cooling to 20 °C, H2O was added. The organic and the aqueous layers were 
separated and the latter was extracted with CH2Cl2 (15 x 3 ml). The combined organic layers 
were dried (Na2SO4), filtered and the filtrate was concentrated in vacuo. The residue was 
purified by column chromatography (flash silica gel, heptanes / dichloromethane = 1:1). 
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2,7-Bis(methoxycarbonyl)-3,6-dichlorobenzo[1,2-b;5,6-b']dithiophene (2); Starting with 1 
(2.00 g, 9.16 mmol), SOCl2 (6 ml, 80 mmol), pyridine (0.2 
ml), following the general procedure A, 2 was isolated as a 
yellow crystalline solid (1.94 g, 57 %), mp. 147-149 °C. 1H 
NMR (300 MHz, CDCl3): δ =  3.93 (s, 6H, OCH3), 7.95 (s, 
2H, Ar); 13C NMR (75.5 MHz, CDCl3): δ = 52.7 (OCH3), 121.3 (CH), 126.2, 128.5, 133.1, 
137.0, 160.7 (C); IR (KBr): v = 3434, 2960, 2842, 1727 (s), 1650, 1643, 1633, 6113, 1509, 
1434 (m), 1322, 1306, 1250, 1238, 1010, 1090, 1038 (s), 973, 940, 910, 817, 759, 736, 611 
(m)  cm-1.;  GC-MS (EI, 70 eV): m/z (%) =  374 (M+, 2 x 35Cl, 100), 343 (89), 315 (43), 256 
(29); HRMS (EI, 70 eV): calcd for C14H8Cl2O4S2 (2 x 35Cl) [M]+: 373.9276; found: 373.9274.  
2,7-Bis(butoxycarbonyl)-3,6-dichlorobenzo[1,2-b;5,6-b']dithiophene (3): Starting with 1 
(2.00 g, 9.16 mmol), SOCl2 (6 ml, 80 mmol) and pyridine 
(0.2 ml), following the general procedure A, 3 was obtained 
as a yellow crystalline solid (2.73 g, 65 %), mp. 95-97 °C.  
1H NMR (300 MHz, CDCl3): δ =  0.94 (t, J = 7.3 Hz, 6H, 
CH3), 1.39-1.46 (m, 4H, CH2), 1.68-1.77 (m, 4H, CH2), 4.34 (t, J = 6.5 Hz, 4H, OCH2), 7.91 
(s, 2H, Ar); 13C NMR (75.5 MHz, CDCl3): δ = 13.7 (CH3), 19.2, 30.6 (CH2), 65.9 (OCH2), 
121.2 (CH), 126.2, 128.2, 132.9, 137.1, 160.8 (C); IR (KBr): v = 3418, 2956, 2931, 2872 (s), 
2736 (w) 1726, 1708, 1510, 1494 (s), 1476, 1406, 1380, 1301 (m), 1235, 1211, 1095, 1082, 
1060, 1045, 1017, 964 (s), 932, 850, 804, 756 (m), 756, 734, 715 (s) cm-1.;  GC-MS (EI, 
70 eV): m/z (%) = 458 (M+, 2 x 35Cl, 100), 346 (78), 329 (41), 257 (33); HRMS (EI, 70 eV): 
calcd for C20H20Cl2O4S2 (2 x 35Cl) [M]+: 458.0280; found: 458.0171.  
6.1.3 Synthesis of unsymmetrical Benzo[1,2-b;5,6-b']dithiophenes derivatives (5a-c) 
2,7-Bis(butoxycarbonyl)-3-(5-fluoro-2-methoxyphenyl)-6-chlorobenzo[1,2-b;5,6-b'] 
dithiophene (5a): Starting with 3 (200 mg, 0.43 mmol), 5-
fluoro-2-methoxyphenylboronic acid 4a (1.2 equiv. 88 mg, 
0.53 mmol), Pd(PPh3)4 (25 mg, 5 mol %), K3PO4 (2.0 equiv., 
185 mg, 0.85 mmol), and 1,4-dioxane (5 ml), following the 
general procedure B, 5a was isolated as a white solid (195 mg, 82 %), mp. 108-110 °C. 1H 
NMR (300 MHz, CDCl3): δ = 0.79 (t, J = 7.3 Hz, 3H, CH3), 0.92 (t, J = 7.3 Hz, 3H, CH3), 
1.11-1.38 (m, 2H), 1.40-1.48 (m, 4H), 1.66-1.74 (m, 2H),  3.61 (s, 3H, OCH3), 4.10 (t, 
J = 6.3 Hz, 2H), 4.31 (t, J = 6.3 Hz, 2H), 6.86-6.95 (m, 2H), 7.04-7.10 (td, J = 8.1, 3.1 Hz, 
1H), 7.36 (d, J = 8.8 Hz, 1H), 7.74 (d, J = 8.8 Hz, 1H); 19F NMR (282.4 MHz, CDCl3): δ = -
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124.0. 13C NMR (75.5 MHz, CDCl3): δ = 13.3, 13.7 (CH3), 19.0, 19.2 (CH2), 30.5, 30.6 
(CH2), 56.1 (OCH3), 65.4, 65.7 (OCH2), 111.9 (d, JF,C = 8.3 Hz, CH), 115.9 (d, JF,C = 22.5 
Hz, CH), 117.9 (d, JF,C = 23.6 Hz, CH), 120.5, 122.5 (CH), 124.6 (d, JF,C = 8.2 Hz, CH), 
128.2, 130.5, 133.0, 134.2, 136.3, 139.2, 139.8, 153.5 (C), 156.1 (d, JF,C = 237.7 Hz, CF), 
161.0, 162.0; IR (KBr): v = 2958, 2932, 1872, 2836, 1718, 1697 (s), 1493, 1463, 1414, 1334, 
1311 (m), 1273, 1255, 1227, 1206, 1180, 1155, 1125, 1085, 1069, 1029 (s), 992, 940, 907, 
877 (m), 807, 757, 729 (s) cm-1; GC-MS (EI, 70 eV): m/z (%) = 548 (M+, 35Cl, 97), 475 (48), 
461 (41), 447 (13) 405 (32), 391 (22), 381 (34), 359 (31), 325 (21); HRMS (EI, 70 eV): calcd 
for C27H26ClFO5S2 (35Cl) [M]+: 548.0889; found: 548.0890. 
2,7-Bis(butoxycarbonyl)-3-(5-chloro-2-methoxyphenyl)-6-chlorobenzo[1,2-b;5,6-b'] 
dithiophene (5b): Starting with 3 (200 mg, 0.43 mmol), 5-
chloro-2-methoxyphenylboronic acid 4b (1.2 equiv., 96 mg, 
0.51 mmol), Pd(PPh3)4 (25 mg, 5 mol %), K3PO4 (2.0 equiv. 
185 mg, 0.85 mmol), and 1,4-dioxane (5 ml), following the 
general procedure B, 5b was isolated as  a light green solid (211 mg, 87 %), mp. 77-99 °C. 1H 
NMR (300 MHz, CDCl3): δ =  0.81 (t, J = 7.3 Hz, 3H, CH3), 0.93 (t, J = 7.3 Hz, 3H, CH3), 
1.14-1.21 (m, 2H), 1.38-1.42 (m, 4H), 1.44-1.48 (m, 2H),  3.60 (s, 3H, OCH3), 4.13 (t, 
J = 6.5 Hz, 2H), 4.32 (t, J = 6.5 Hz, 2H), 6.88 (d, J = 8.8 Hz, 1H), 7.16 (d, J = 2.6 Hz, 1H), 
7.30-7.36 (m, 2H), 7.73 (d, J = 8.8 Hz, 1H); 13C NMR (75.5 MHz, CDCl3): δ = 13.7, 13.8 
(CH3), 19.1, 19.2 (CH2), 30.5, 30.6 (CH2), 55.8 (OCH3), 65.5, 65.7 (OCH2), 112.1, 120.5, 
122.5 (CH), 124.9, 125.3, 125.4, 128.2 (C), 129.6, 130.6 (CH), 130.7, 133.0, 134.2, 136.3, 
138.9, 139.8, 155.9, 161.0, 162.0 (C); IR (KBr): v = 2974, 2961, 2930, 2911, 2825, 1721, 
1686 (s), 1675, 1663, 1582, 1561 (w), 1481, 1479, 1461, 1411, 1403, 1338, 1334 (m), 1289, 
1261, 1251, 1182, 1134, 1127, 1025 (s), 802, 769, 684, 667 (s) cm-1; GC-MS (EI, 70 eV): m/z 
(%) = 564 (M+, 35Cl, 100), 491 (24), 477 (36), 463 (11), 421 (31),  381 (37) 325 (24); HRMS 
(EI, 70 eV): calcd for C27H26Cl2O5S2 (35Cl) [M]+: 564.0593; found: 564.0594. 
2,7-Bis(butoxycarbonyl)-3-(2-methoxyphenyl)-6-chlorobenzo[1,2-b;5,6-b']dithiophene 
(5c): Starting with 3 (200 mg, 0.43 mmol), 2-
methoxyphenylboronic acid 4c (1.2 equiv., 78 mg, 0.52 mmol), 
Pd(PPh3)4 (25 mg, 5 mol%), K3PO4 (2.0 equiv. 185 mg, 0.85 
mmol), and 1,4-dioxane (5 ml), following the general 
procedure B, 5c was isolated as a light green highly viscous oil (180 mg, 80 %).  1H NMR 
(300 MHz, CDCl3): δ =  0.79 (t, J = 7.3 Hz, 3H, CH3), 0.92 (t, J = 7.3 Hz, 3H, CH3), 1.11-
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1.20 (m, 2H), 1.40-1.46 (m, 4H), 1.66-1.74 (m, 2H),  3.61 (s, 3H, OCH3), 4.10 (t, J = 6.3 Hz, 
2H), 4.31 (t, J = 6.5 Hz, 2H), 6.95 (d, J = 8.3 Hz, 1H), 7.01 (td, J = 7.4, 1.2 Hz, 1H), 7.17 (dd, 
J = 7.4, 1.7 Hz, 1H), 7.34-7.39 (m, 2H), 7.71 (d, J = 8.8 Hz, 1H); 13C NMR (75.5 MHz, 
CDCl3): δ = 13.7, 13.8 (CH3), 19.1, 19.2 (CH2), 30.5, 30.6 (CH2), 55.8 (OCH3), 65.5, 65.7 
(OCH2), 110.9, 120.2, 120.5 (CH), 123.2, 125.2 (CH), 128.2 (C), 129.9 (CH), 130.1 (C), 
130.9 (CH), 133.0, 134.1, 136.1, 140.2, 140.7, 157.1, 161.0, 162.2; IR (KBr): v = 2957, 2930, 
2872, 1716, 1698 (s), 1547, 1531, 1501, 1486, 1462, 1413, 1337, 1311 (m), 1274, 1228, 1175, 
1123, 1114, 1071 (s) 906, 875, 727 (s) cm-1; GC-MS (EI, 70 eV): m/z (%) = 530 (M+, 35Cl, 
100), 457 (49), 443 (33), 381 (37), 325 (21); HRMS (EI, 70 eV): calcd for C27H27ClO5S2 
(35Cl) [M]+: 530.0982; found: 530.0981. 
 
6.1.4 Synthesis of symmetrical Benzo[1,2-b;5,6-b']dithiophenes derivatives (6) 
 
General procedure C for Suzuki–Miyaura reactions: 1,4-dioxane solution (5 ml) of Pd(PPh3)4 
(5 mol%) and SPhos (10 mol%) was stirrered for 10 minutes. Adding substrate (1.0 equiv.), 
K3PO4 (4.0 equiv.), arylboronic acids (2.5 equiv.) was stirred at 110-130 °C for 4 h. After 
cooling to 20 °C, H2O was added. The organic and aqueous layers were separated and the 
latter was extracted with CH2Cl2 (15 x 3 ml). The combined organic layers were dried passing 
through (Na2SO4), filtered and the filtrate was concentrated in vacuo. The residue was 
purified by column chromatography (flash silica gel, heptanes / dichloromethane = 1:1) to 
obtain compound 6b,c. 
2,7-Bis(butoxycarbonyl)-3,6-bis(5-chloro-2-methoxyphenyl)benzo[1,2-b;5,6-b'] 
dithiophene (6b): Starting with 3 (200 mg, 0.43 mmol), 
5-chloro-2-methoxyphenylboronic acid 4b (2.5 equiv., 
220 mg, ), Pd(PPh3)4 (25 mg, 5 mol %), SPhos (20 mg, 
10 mol%), K3PO4 (4.0 equiv. 370 mg), and 1,4-dioxane 
(5 ml), following the general procedure C, 6b was isolated as  a light green solid. 1H NMR 
(300 MHz, CDCl3): δ =  0.82 (t, J = 7.3 Hz, 6H, CH3), 1.15-1.22 (m, 4H, CH2), 1.14-1.49 (m, 
4H), 1.38-1.42 (m, 4H), 3.58 (s, 6H, OCH3),  4.12 (t, J = 6.4 Hz, 4H), 6.85 (dd, J = 8.8, 2.8 
Hz, 2H), 7.13 (d, J = 2.5 Hz, 2H), 7.21 (s, 2H), 7.27-7.31 (m, 2H); 13C NMR (75.5 MHz, 
CDCl3): δ = 13.7 (CH3), 19.1 (CH2), 28.7 (CH2), 55.8 (OCH3), 65.4 (OCH2), 112.1, 121.7, 
129.4, 130.7 (CH), 125.4, 128.2, 130.7, 133.0, 134.4, 139.1, 155.9, 162.2 (C); HRMS (EI, 
70 eV): calcd for C34H32Cl2O6S2 (35Cl) [M]+: 670.6513; found: 670.6509. 
SS COOBuBuOOC
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2,7-Bis(butoxycarbonyl)-36-bis(2-methoxyphenyl)benzo[1,2-b;5,6-b']dithiophene Starting 
with 3 (200 mg, 0.43 mmol), 5-chloro-2-
methoxyphenylboronic acid 4b (2.5 equiv., 220 mg), 
Pd(PPh3)4 (25 mg, 5 mol %), SPhos (20 mg, 10 mol %), 
K3PO4 (4.0 equiv., 370 mg), and 1,4-dioxane (5 ml), 
following the general procedure C, 6c was isolated as  a crystalline solid. mp. 108-110 °C;  1H 
NMR (300 MHz, CDCl3): δ =  0.82 (t, J = 7.4 Hz, 6H, CH3), 1.15-1.24 (m, 4H, CH2), 1.14-
1.51 (m, 4H), 1.38-1.42 (m, 4H), 3.55 (s, 6H, OCH3),  4.13 (t, J = 6.5 Hz, 4H), 6.63-6.67 (m, 
6H), 7.12 (dd, J = 8.4, 2.5 Hz, 2H), 7.29 (s, 2H); 13C NMR (75.5 MHz, CDCl3): δ = 13.7 
(CH3), 19.1 (CH2), 28.7 (CH2), 55.8 (OCH3), 65.4 (OCH2), 112.1, 121.7, 128.6, 129.4, 130.7 
(CH), 125.4, 130.7, 131.0 133.0, 134.4, 139.1, 155.1, 162.3 (C); HRMS (EI, 70 eV): calcd for 
C34H34O6S2 (35Cl) [M]+: 602.1764; found: 602.1764. 
 
6.2 Synthesis of diarylatedbenzodithiazol derivatives  
6.2.1 General procedure D for the synthesis of (9a-f). 
To a cold suspension of 1,3-benzenediamine 7 (1.0 equiv., 18.5 mmol) and NEt3 (5.1 ml, 37 
mmol, 2.0 equiv.) in dry dichloromethane (50ml), dichloromethane solution (10 ml) of 
benzoyl chloride 8a-g (2.0 equiv.) was added drop wise. The reaction mixture was stirred at 
20 °C for 12 h and subsequently poured into 100 ml of water. The organic layer was 
separated, washed with aqueous solution of NaHCO3 and with water (30 ml), and dried 
through Mg2SO4. The solution was later concentrated under reduced pressure. 
N,N'-(1,3-Phenylene)bis(4-chlorobenzamide) (9a); Starting with 7 (2.00 g, 18.5 mmol, 1.0 
equiv.), triethylamine (5.1 ml, 37 mmol, 2.0 equiv.), 
4-chlorobenzoyl chloride (4.7 ml, 37 mmol, 2.0 
equiv.), dichloromethane (25 ml), following the 
general procedure D, 9a was isolated as a white 
solid (3.91 g, 55 %); 1H NMR (300 MHz, DMSO-d6): δ = 7.34 (d, J = 3.6 Hz, 1H ), 7.51 (dd, 
J = 7.8, 2.0 Hz, 2H), 7.59-7.64 (m, 4H), 7.99-8.03 (m, 4H), 8.33 (t, 1H), 10.8 (s, 2H, NH); 13C 
NMR (75.5 MHz, DMSO-d6): δ = 112.9, 116.2, 128.3, 128.6, 129.6 (CH), 133.5, 136.3, 
139.1, 164.4 (CO); GC-MS (EI, 70 eV): m/z (%) = 384 (M+, 100), 139 (89), 111 (34), 75 (23); 
HRMS (EI, 70 eV): calcd for C20H14Cl2N2O2 (35Cl) [M]+: 385.0505; found: 385.0505. 
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 N,N'-(1,3-Phenylene)bis(4-fluorobenzamide) 9b; Starting with 7 (2.00 g, 18.5 mmol, 1.0 
equiv.), triethylamine (5.1 ml, 37 mmol, 2.0 equiv.), 
4-fluorobenzoyl chloride (5.1 ml, 37 mmol, 2.0 
equiv.), dichloromethane (25 ml), following the 
general procedure D, 9b was isolated (3.62 g, 60 %);  
1H NMR (300 MHz, DMSO-d6): δ =  7.29-7.34 (m, 5H), 7.51 (dd, J = 8.4, 2.6 Hz, 2H), 7.99-
8.11 (m, 4H), 8.39 (t, 1H), 10.3 (s, 2H, NH) ; 19F NMR (282.4 MHz, DMSO): δ = -108.8; 13C 
NMR (75.5 MHz, DMSO): δ = 112.9 (CH), 115.1 (d, JF,C  = 23.7 Hz, CH), 116.1, 128.5 (CH), 
130.3 (d, JF,C  = 9.8 Hz, CH) 131.3 (d, JF,C = 2.6 Hz, C), 139.2 (C), 164.3 (d, JF,C =264 Hz, 
CF), 166.0 (CO); GC-MS (EI, 70 eV): m/z (%) = 352 (M+,100), 139 (89), 111 (34), 75 (23); 
HRMS (EI, 70 eV): calcd for C20H14F2N2O2 [M]+: 352.2351; found: 352.2349. 
N,N'-(1,3-Phenylene)bis(4-methylbenzamide); Starting with 7 (2.00 g, 18.5 mmol, 1.0 
equiv.), triethylamine (5.1 ml, 37 mmol, 2.0 
equiv.), 4-methylbenzoyl chloride (4.8 mg, 37 
mmol, 2.0 equiv.), dichloromethane (25 ml), 
following the general procedure D, 9c was 
isolated (3.5 g, 55 %). mp. 257-259 °C.  1H NMR (300 MHz, DMSO-d6): δ = 3.37 (s, 6H, 
CH3), 7.29-7.37 (m, 5H), 7.51 (dd, J = 7.9, 1.8 Hz, 2H), 7.92 (d, J = 8.2 Hz, 4H), 8.34 (t, J = 
3.2 Hz, 1H), 10.2 (s, 2H, NH); 13C NMR (75.5 MHz, DMSO-d6): δ = 20.7 (2-CH3), 112.9, 
115.9, 127.7, 128.4, 128.8 (CH), 132.0, 139.3, 141.5, 165.3 (CO); GC-MS (EI, 70 eV): m/z 
(%) = 344 (M+, 67), 119 (99), 91 (44), 65 (13); HRMS (EI, 70 eV): calcd for C22H20N2O2 
[M]+: 344.1519; found: 344.1522.  
N,N'-(1,3-Phenylene)bis(phenylbenzamide) 9d; Starting with 7 (2.00 g, 18.5 mmol, 1.0 
equiv.), triethylamine (5.1 ml, 37 mmol, 2.0 equiv.), 
benzoyl chloride (4.8 ml, 37 mmol, 2.0 equiv.), 
dichloromethane (25 ml), following the general procedure 
D, 9d was isolated (3.26 g, 57 %).  1H NMR (300 MHz, DMSO-d6): δ =  7.37 (d, J = 3.2 Hz, 
1H ), 7.54-7.65 (m, 8H), 8.01-8.05 (m, 4H), 8.39 (t, 1H), 10.36 (s, 2H, NH); 13C NMR 
(75.5 MHz, DMSO-d6): δ = 112.9, 116.0, 127.6, 128.3, 128.5, 131.4 (CH), 134.9, 139.3, 
165.4 (CO);  GC-MS (EI, 70 eV): m/z (%) = 316 (M+, 87), 119 (99), 91 (44), 65 (13); HRMS 
(EI, 70 eV): calcd for C20H16N2O2 [M]+: 316.3501; found: 316.3502. 
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N,N'-(1,3-Phenylene)dipropionamide (9e) Starting with 7 (2.00 g, 18.5 mmol, 1.0 equiv.), 
triethylamine (5.1 ml, 37 mmol, 2.0 equiv.), propanoyl chloride 
(1.8 ml, 37 mmol, 2.0 equiv.), dichloromethane (25 ml), 
following the general procedure D, 9e was isolated (1.80 g, 60 
%).  1H NMR (300 MHz, DMSO-d6): δ = 1.09 (t, J = 7.6 Hz, 6H, CH3), 2.32 (q, 4H, CH2), 
7.18 (t, J = 1.6 Hz, 1H), 7.28 (d, J = 6.3 Hz, 2H), 7.93 (s, 1H), 9.84 (s, 2H, NH); 13C NMR 
(75.5 MHz, DMSO-d6): δ = 9.6 (CH3), 29.4 (CH2), 109.9, 113.7, 128.6 (CH), 139.5, 171.8 
(CO);  GC-MS (EI, 70 eV): m/z (%) = 221 (M+, 64), 164 (49), 108 (94), 80 (17); HRMS (EI, 
70 eV): calcd for C12H16N2O2 [M]+: 221.1284; found: 221.1282. 
N,N'-(1,3-Phenylene)bis(2,2-dimethylpropanamide) (9f) Starting with 7 (2.00 g, 18.5 
mmol), triethylamine (5.1 ml, 37 mmol, 2.0 equiv.), 2,2-
dimethylpropanoyl chloride (4.5 ml, 37 mmol, 2 equiv.), 
dichloromethane (25 ml), following the general procedure D, 
9f was isolated (2.87 mg, 54 %).  1H NMR (300 MHz, CDCl3): δ = 1.13 (s, 18 H, CH3), 7.13 
(t, J = 1.8 Hz, 1H), 7.20-7.23 (m, 3H), 7.36 (s, 2H, NH); 13C NMR (75.5 MHz, CDCl3): 
δ = 27.5 (CH3), 39.6 (C), 111.4, 115.5, 129.3 (CH), 138.5, 176.8 (CO);  GC-MS (EI, 70 eV): 
m/z (%) = 276 (M+, 74), 192 (43), 108 (15), 57 (88); HRMS (EI, 70 eV): calcd for 
C16H24N2O2 [M]+: 277.1910; found: 277.1908.                         
6.2.2 General procedure E for the synthesis of (10a-f). 
The amide starting material (0.5 mmol), Lawesson’s reagent (0.5 mmol), were refluxed in 
toluene (30 ml) for one hour. The reaction mixture was continuously stirred. Upon cooling, 
toluene solvent was evaporated using rotary evaporator. The crude mixture was purified by 
silica gel column chromatography using (dichloromethane / hexane, 1:1) to obtain the deep 
yellow colored compounds 10a-f in high yields 76-82 %. 
N,N'-(1,3-Phenylene)bis(4-chlorobenzothioamide) (10a) Starting with 9a (1.00 g, 1.0 
equiv.), Lawesson’s reagent (0.80 g, 1.0 equiv.), 
toluene (25 ml), following the general procedure E, 
10a was isolated as a yellow solid (1.23 g, 95 %). 
mp. 227-229 °C;  1H NMR (300 MHz, DMSO-d6): 
δ = 7.52-7.58 (m, 5H ), 7.71 (d, J = 7.2 Hz, 2H), 7.88 (d, 8.4 Hz, 4H), 8.40 (s, 1H), 11.9 (s, 
2H, NH), ; 13C NMR (75.5 MHz, DMSO-d6): δ = 119.6, 122.1, 128.0, 128.5, 129.2 (CH), 
135.5, 139.9, 141.0, 196.13 (CS); GC-MS (EI, 70 eV): m/z (%) = 417 (M+, 87), 139 (89), 111 
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(34), 75 (23); HRMS (EI, 70 eV): calcd for C20H14Cl2N2S2 (35Cl) [M]+: 417.6413; found: 
417.6411.  
 N,N'-(1,3-Phenylene)bis(4-flourobenzothioamide) (10b) Starting with 9b (1.00g, 1.0 
equiv.), Lawesson’s reagent (0.80 g, 1.0 equiv.),  
toluene (25 ml), following the general procedure E, 
10b was isolated 1.18 g, 93 %).  mp. 235-237 °C; 1H 
NMR (300 MHz, DMSO-d6): δ = 7.34-7.40 (m, 4H), 
7.53-7.77 (m, 3H), 7.99 (dd, J = 8.4, 2.7 Hz, 4H), 8.43 (s, 1H), 11.91 (s, 2H, NH); 19F NMR 
(282.4 MHz, DMSO-d6): δ = -109.9; 13C NMR (75.5 MHz, DMSO-d6): δ = 114.8 (d, JF,C = 
21.2 Hz, CH), 121.1 (d, JF,C = 4.2 Hz, C), 128.5, 129.9, 130.1 (CH), 138.8 (d, JF,C = 203.2 Hz, 
C), 140.1, 196.2 (CS); GC-MS (EI, 70 eV): m/z (%) = 384 (M+, 59), 351 (23), 244 (34), 230 
(66), 139 (96); HRMS (EI, 70 eV): calcd for C20H14F2N2S2 [M]+: 384.0561; found: 384.0558.  
 N,N'-(1,3-Phenylene)bis(4-methylbenzothioamide) (10c) Starting with 9c (1.00g, 1.0 
equiv.), Lawesson’s reagent (0.80 g, 1.0 equiv.), 
toluene (25 ml), following the general procedure 
E, 10c was isolated (1.34 g, (92 %);  1H NMR 
(300 MHz, DMSO-d6): δ = 2.39 (s, 6H, CH3), 
7.29 (d, J = 8.1 Hz, 4H), 7.49 (t, 3H), 7.69 (d, J = 7.6 Hz, 4H), 8.35 (s, 1H), 11.74 (s, 2H, 
NH); 13C NMR (75.5 MHz, DMSO-d6): δ = 20.8 (CH3), 120.1, 122.2, 127.5, 128.3, 128.5 
(CH), 139.4, 140.1, 140.9, 197.4 (CS); GC-MS (EI, 70 eV): m/z (%) = 376 (M+, 76), 343 (67), 
240 (43), 226 (93), 135 (70); HRMS (EI, 70 eV): calcd for C22H20N2S2 [M]+: 377.1140; 
found: 377.1138. 
 N,N'-(1,3-Phenylene)bis(benzothioamide) (10d) Starting with 9d (1.00g, 1.0 equiv.), 
Lawesson’s reagent (0.80 g, 1.0 equiv.), toluene (25 ml), 
following the general procedure E, 10d was isolated as a 
coloured solid (1.17 g, (94 %);  mp. 214-216 °C.  1H NMR 
(300 MHz, DMSO-d6): δ = 7.49-7.58 (m, 7H), 7.76 (d, J = 7.2 Hz, 2H), 7.88 (d, J = 7.2 Hz, 
4H), 8.47 (s, 1H), 11.89 (s, 2H, NH);  13C NMR (75.5 MHz, DMSO-d6): δ = 119.7, 122.1, 
127.4, 127.8, 128.4, 130.8 (CH), 140.1, 142.5 (C), 197.7 (CS); GC-MS (EI, 70 eV): m/z (%) = 
348 (M+, 97), 315 (49), 226 (40), 212 (87) , 121 (99); HRMS (EI, 70 eV): calcd for 
C20H16N2S2 [M]+: 348.0749; found: 348.0744. 
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N,N'-(1,3-Phenylene)dipropanethioamide (10e) Starting with 9e (1.00g, 1.0 equiv.), 
Lawesson’s reagent (0.80 g, 1.0 equiv.), toluene (25 ml), 
following the general procedure E, 10e was isolated (1.32 g, 
(90 %). mp. 158-160 °C;  1H NMR (300 MHz, DMSO-d6): 
δ = 1.28 (t, J = 7.4 Hz,  6H, CH3), 2.78 (q, 4H, CH2), 7.20 (t, J = 2.2 Hz, 1H), 7.34-7.8 (m, J = 
7.1 Hz, 3H), 11.57 (s, 2H, NH); 13C NMR (75.5 MHz, DMSO-d6): δ = 14.1 (CH3), 39.4 
(CH2), 120.8, 128.3, 139.5 (CH), 161.1 (C), 205.5 (CS); GC-MS (EI, 70 eV): m/z (%) = 252 
(M+, 84), 164 (57); HRMS (EI, 70 eV): calcd for C12H16N2S2 [M]+: 252.3952; found: 
252.3949. 
 N,N'-(1,3-Phenylene)bis(2,2-dimethylpropanethioamide) (10f) Starting with 9f (1.00g, 1.0 
equiv.), Lawesson’s reagent (0.80 g, 1.0 equiv.), toluene (25 
ml), following the general procedure E, 10f was isolated (1.2 
g, (91 %);  mp. 148-150 °C;  1H NMR (300 MHz, CDCl3): 
δ = 1.40 (s, 18H, CH3), 7.36 (t, J = 1.3 Hz, 3H), 7.80 (s, 1H), 13C NMR (75.5 MHz, CDCl3): 
δ = 30.3 (CH3), 45.5 (C), 121.9, 123.8, 129.4 (CH), 139.5, 214.1 (CS); GC-MS (EI, 70 eV): 
m/z (%) = 308 (M+, 64), 251 (23), 192 (95); HRMS (EI, 70 eV): calcd for C16H24N2S2 [M]+: 
308.5282; found: 308.5284.  
6.2.3 Preparation of N-Benzyl-DABCO Tribromide. 
To a stirred solution of DABCO (0.30 g, 1.0 equiv.) in dioxane (5 ml), a solution of benzyl 
bromide (0.22 g, 1.0 equiv.) in dioxane (5 ml) was added slowly for about 20 minutes. Then, a 
solution of  bromine (0.12 g, 1.0 equiv.) in dioxane (5 ml) was cautiously  added under 
vigorous stirring. After cooling the solution, the  resulting orange crystals were filtered and 
dried. (1.72 g, 84 %).   
6.2.4 General Procedure F for the oxidative cyclization of thiobenzanilides.  
To a stirred solution of thiobenzanilide (1.0 equiv.) in CH2Cl2 / CCl4 (1:1, 10 ml), N-Benzyl 
DABCO tribromide (2.0 equiv.) was added. The reaction mixture was stirred for 30 to 90 min 
at 20 °C. The solvent was removed under reduced pressure and the residue was subjected to 
column chromatography (CH2Cl2 / hexane, 1:1) to obtain the cyclised products 11a-f.   
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1,4-Bis[4-(Chlorophenyl]benzo[1,2-d:4,5-d]bisdithiazole (11a); Starting with 10a (200 mg, 
1.0 equiv.), N-Benzyl DABCO tribromide (450 
mg, 2.0 equiv.), dichloromethane/carbon 
tetrachloride (1:1, 10 ml), following the general procedure F, 11a was isolated as white solid 
(113 mg, 78 %); mp. 284-285 °C.;  1H NMR (300 MHz, DMSO-d6): δ = 7.34 (d, J = 8.2 Hz, 
4H), 7.87 (d, J = 8.3 Hz, 4H), 8.02 (s, 1H), 8.10 (s, 1H); 13C NMR (75.5 MHz, DMSO-d6): 
δ = 119.4, 127.9, 128.5, 129.2 (CH), 131.3, 134.4, 141.2, 146.3, 169.3 (C); GC-MS (EI, 
70 eV): m/z (%) = 413 (M+, 100), 275 (18), 240 (23), 206 (12), 138 (33); HRMS (EI, 70 eV): 
calcd for C20H10Cl2N2S2 [M]+: 411.9657; found: 411.9661. 
1,4-Bis[4-(Flourophenyl]benzo[1,2-d:4,5-d]bisdithiazole (11b); Starting with 10b (200 mg, 
1.0 equiv.), N-Benzyl DABCO tribromide (450 mg, 
2.0 equiv.),  dichloromethane/carbon tetrachloride 
(1:1, 10 ml), following the general procedure F, 11b was isolated as yellowish solid (118 mg, 
65 %).  1H NMR (300 MHz, DMSO-d6): δ = 7.34 -7.40 (m, 4H), 7.53-7.77 (m, 3H), 7.99 (dd, 
J = 8.4, 2.7 Hz, 4H), 8.43 (s, 1H); 19F NMR (282.4 MHz, DMSO-d6): δ = -108.7; 13C NMR 
(75.5 MHz, DMSO-d6): δ = 115.2 (d, JF,C  = 22.1 Hz, CH), 118.8 (CH), 119.3 (CH), 128. 4 (d, 
JF,C  =  8.3 Hz, CH), 126.6, 130.6, 152.1 (C), 163 (d, JF,C = 203.7 Hz, CF); GC-MS (EI, 
70 eV): m/z (%) = 380 (M+,100), 259 (23), 190 (14); HRMS (EI, 70 eV): calcd for 
C20H10F2N2S2 [M]+: 381.0326; found: 381.0322. 
1,4-Bis[4-(Methyl-phenyl]benzo[1,2-d:4,5-d]bisdithiazole (11c); Starting with 10c (200 
mg, 1.0 equiv.), N-Benzyl DABCO tribromide 
(450, 2.0 equiv.), dichloromethane/carbon 
tetrachloride (1:1, 10 ml), following the general procedure F, 11c was isolated as a yellow 
solid (138 mg, 70 %); mp. 221-223 °C; 1H NMR (300 MHz, DMSO-d6): δ = 2.38 (s, 6H, 
CH3), 7.31 (d, J = 8.1 Hz, 4H), 7.98 (d, J = 8.4 Hz, 6H); 13C NMR (75.5 MHz, DMSO-d6): 
δ = 26.3 (CH3), 124.8, 125.1, 132.2, 134.8 (CH), 135.3, 141.4, 146.6, 158.6, 172.2 (C); GC-
MS (EI, 70 eV): m/z (%) = 372 (M+, 100), 186 (16), 138 (43); HRMS (EI, 70 eV): calcd for 
C22H16N2S2 [M]+: 372.0749; found: 372.0751. 
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1,4-Bis[4-(Phenyl]benzo[1,2-d:4,5-d]bisdithiazole (11d); Starting with (200 mg, 1.0 equiv.), 
N-Benzyl DABCO tribromide (450 mg, 2.0 equiv.), 
dichloromethane/carbon tetrachloride (1:1, 10 ml), 
following the general procedure F, 11d was isolated (140 mg, 70 %). mp. 238-240 °C.  1H 
NMR (300 MHz, DMSO-d6): δ = 7.28-7.30 (m, 6H), 7.65-7.98 (m, 6H); 13C NMR 
(75.5 MHz, DMSO-d6): δ = 116.1, 125.5, 127.6, 128.3, 133.5 (CH), 131.5, 134.9, 139.3, 
165.5 (C); GC-MS (EI, 70 eV): m/z (%) = 344 (M+, 98), 267 (56), 189 (34); HRMS (EI, 
70 eV): calcd for C20H12N2S2 [M]+: 344.2431; found: 344.2427. 
1,4-Bis[tert.butyl]benzo[1,2-d:4,5-d]dithiazole (11e); Starting with 10e (200 mg, 1.0 
equiv.), N-Benzyl DABCO tribromide (450 mg, 2.0 equiv.), 
dichloromethane/carbon tetrachloride (1:1, 10 ml), following 
the general procedure F, 11e was isolated (128 mg, 78 %).  1H NMR (300 MHz, DMSO-d6): 
δ = 1.31 (s, 18H, CH3), 7.83 (s, 1H), 8.96 (s, 1H); 13C NMR (75.5 MHz, DMSO-d6): δ = 26.6 
(CH3), 40.2 (C), 116.7, 132.3 (CH), 135.6, 138.3, 176.7 (C); GC-MS (EI, 70 eV): m/z (%) = 
304 (M+, 94), 246 (53), 188 (15); HRMS (EI, 70 eV): calcd for C16H20N2S2 [M]+: 304.2619; 
found: 304.2623.    
1,4-Bis[Ethyl]benzo[1,2-d:4,5-d]dithiazole (11f); Starting with 10f (200 mg, 1.0 equiv.), N-
Benzyl DABCO tribromide (450 mg, 2.0 equiv.), 
dichloromethane/carbon tetrachloride (1:1, 10 ml), 
following the general procedure F, 11f was isolated (142 mg, 78 %).  1H NMR (300 MHz, 
DMSO-d6): δ = 1.31 (t, J = 2.1 Hz, 6H, CH3), 3.12 (q, 4H, CH2); 13C NMR (75.5 MHz, 
DMSO-d6): δ = 14.7 (CH3), 34.1 (CH2), 116.8, 132.5 (CH), 135.6, 138.2, 171.0 (C); GC-MS 
(EI, 70 eV): m/z (%) = 248 (M+, 84), 216 (63); HRMS (EI, 70 eV): calcd for C12H12N2S2 
[M]+: 248.3651; found: 248.3647.       
6.3 Chemoselective S-M Cross Coupling Reaction Studies of 2-Bromo-1-
(trifluoromethanesulfonyloxy) naphthalene, 
6.3.1 General procedure G for the synthesis of 13, 21 and 25.  
A benzene suspension (30 ml) of 1-tetralone 12, 20, 24 (1.0 equiv.), N-bromosuccinimide 
(NBS) (2.2 equiv.) and (PhCOO)2 (5 mol %) was refluxed under Argon atmosphere for 4 h 
and then cooled to 20 °C. To the reaction mixture was added triethylamine (1 ml) and the 
solvent was removed in vacuo. The reaction mixture was diluted with water and extracted 
with CH2Cl2 (3 x 25 ml). The combined organic layers were dried (Na2SO4), filtered and the 
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filtrate was concentrated in vacuo. The residue was purified by flash chromatography (silica 
gel, heptane/ EtOAc) to give 13, 21 and 25. 
6.3.2 General procedure H for synthesis of triflate 15, 22 and 27:  
To a solution of 13, 21 or 25 (1.0 equiv.) in CH2Cl2 (2.5 ml/mmol) was added pyridine  (2.0 
equiv.) at 20 °C under an argon atmosphere. After stirring for 10 min at 0 °C, Tf2O (1.5 
equiv.) was added. The mixture was allowed to warm to 20 °C and stirred for further 6 h. The 
reaction mixture was filtered and the filtrate was concentrated in vacuo. The residue was 
directly purified by chromatography without aqueous work up (flash silica gel, 
heptane/EtOAc). 
General procedure B for Suzuki–Miyaura reactions: A 1,4-dioxane (5 ml) solution of 
K3PO4 (1.5 equiv. per cross-coupling step), Pd(PPh3)4 (5 mol %) and aryl-boronic acid 16a-h 
(1.0-1.1 equiv. per cross-coupling step) was stirred at 90-110 °C for 4 h. After cooling to 20 
°C, H2O was added. The organic and the aqueous layers were separated and the latter was 
extracted with CH2Cl2 (15 x 3 ml). The combined organic layer was dried (Na2SO4), filtered 
and the filtrate was concentrated in vacuo. The residue was purified by column 
chromatography (flash silica gel, heptane-EtOAc, 9:1).  
2-Bromonaphth-1-ol (13).  Starting with 1-tetralone (12) (1.8 ml, 13.7 mmol), N-
bromosuccinimide (NBS) (5.40 g, 30.2 mmol) and (PhCOO)2 (0.17 g, 5 mol 
%), following the general procedure G, 13 was isolated as colourless solid 
(2.57 g, 84 %). 1H NMR (250 MHz, CDCl3):   = 5.89 (s, 1H, OH), 7.24 (d, 
J = 8.8 Hz, 1H), 7.38-7.46 (m, 3H), 7.66-7.75 (m, 1H), 8.12-8.19 (m, 1H). 13C NMR (75.5 
MHz, CDCl3):  = 104.0 (C), 121.3, 122.2, 124.1 (CH), 124.4 (C), 124.8, 127.5, 128.3 (CH), 
133.7, 148.1 (C). IR (KBr): v = 3400 (s), 3051, 1958, 1931, 1883, 1877, 1624 (w), 1586, 1574 
(m), 1504 (w), 1453, 1396, 1384, 1347, 1240, 1212, 1202, 1140, 1126, 1054, 1021, 876, 856 
(m), 829, 792, 768, 736 (s), 716, 641, 600, 561 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 222 
(M+ 98), 115 (92). HRMS (EI, 70 eV): calcd for C10H7BrO [M]+ 221.9680; found: 221.9679. 
2-Bromonaphth-1-yl trifluoromethane-sulfonate (15): Starting with 13 (2.40 g, 10.8 mmol) 
in CH2Cl2 (25 ml), pyridine  (1.8 ml, 21.6 mmol) and Tf2O (2.7 ml, 16.4 
mmol) following the general procedure H,  15 was isolated as a light yellow 
oil (3.53 g, 92 %). 1H NMR (300 MHz, CDCl3): δ = 7.56-7.69 (m, 4H), 7.83 
(d, J = 7.8 Hz, 1H), 8.13 (d, J = 8.1 Hz, 1H). 19F NMR (282.4 MHz, CDCl3): δ = -73.0. 13C 
NMR (75.5 MHz, CDCl3): δ = 114.1 (C), 118.5 (q, JC,F = 321.0 Hz, CF3), 121.2, 127.5 (CH), 
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127.9 (C), 128.1, 128.5, 129.4, 129.9 (CH), 133.7, 142.6 (C). IR (KBr): v = 1589, 1501, 1457 
(m), 1408 (s), 1370, 1365 (m), 1203, 1181, 1124 (s), 1032, (m) 1018, 890, 801, 761 (s), 743, 
703, 665, 616, 587 (m) cm−1. GC/MS (EI, 70 eV): m/z (%) = 354 (M+, 100), 223 (52). HRMS 
(EI, 70 eV): calcd for C11H6BrF3O3S: 353.9173 [M]+; found: 353.9171. Rf = 0.71 
(heptane/EtOAC system; 4:1). 
6.3.3 (2-Aryl)naphthalen-1-yl trifluoromethanesulfonates (17a-e) 
(2-Methoxyphenyl)naphthalen-1-yl trifluoromethanesulfonate (17a): Starting with 15 
(258 mg, 0.73 mmol), 2-methoxyphenylboronic acid (111 mg, 0.73 
mmol), Pd(PPh3)4 (42 mg, 5 mol %), K3PO4 (232 mg, 1.1 mmol) and 
1,4-dioxane (5 ml), following the general procedure B, 16a was 
isolated as a yellow solid (167 mg, 60 %). mp. 73- 75 °C. 1H NMR (300 MHz, CDCl3): 
δ = 3.71 (s, 3H, OCH3), 6.91 (d, J = 8.4 Hz, 1H), 7.01 (td, J = 8.4, 1.2 Hz, 1H), 7.35-7.41 (m, 
1H), 7.21 (d, J = 8.4 Hz, 1H), 7.47-7.52 (m, 1H), 7.42 (d, J = 8.4 Hz, 1H), 7.54-7.61 (m, 1H), 
7.83 (t, J = 8.1 Hz, 2H), 8.14 (d, J = 8.4, 1H). 19F NMR (282.4 MHz, CDCl3): δ = -74.1. 13C 
NMR (62.9 MHz, CDCl3): δ = 55.5 (OCH3), 111.9 (CH), 118.0 (q, JF,C = 316.2 Hz, CF3), 
120.6, 121.6, (CH), 126.4, 126.7 (C), 127.4, 127.9, 128.8, 129.2, 129.6, 130.2, 131.8 (CH), 
129.8, 134.4, 142.6, 156.9 (C). IR (KBr): v = 3060, 3026, 3004, 2939, 2837 (w) 1605, 1597, 
1581, 1494, 1466, 1436, 1405, 1361, 1343, 1270, 1254 (m), 1200, 1132, 1079, 1048, 1026, 
1007, 895, 866, 811, 748 (s), 708, 686, 634, 602, 588, 574 (m) cm−1. GC-MS (EI, 70 eV): m/z 
(%) = 382 (M+, 93), 249 (100), 234 (43), 218 (35), 189 (12). HRMS (EI, 70 eV): calcd for 
C18H13F3O4S [M]+: 382.0481; found: 382.0481.  Anal; C, 56.54; H, 3.43; found; C, 56.41; H, 
3.19.                                             
(4-Methylphenyl)naphthalen-1-yl trifluoromethanesulfonate (17b): Starting with 15 (258 
mg, 0.73 mmol), p-tolylboronic acid (100 mg, 0.73 mmol), 
Pd(PPh3)4 (42 mg, 5 mol %), K3PO4 (232 mg, 1.1 mmol) and 1,4-
dioxane (5 ml), following the general procedure B, 16b was 
isolated as a brown solid (195 mg, 73 %). mp. 71-73 °C. 1H NMR (300 MHz, CDCl3): 
δ = 2.23 (s, 3H, CH3), 7.21 (d, J = 8.1 Hz, 2H), 7.37 (d, J = 8.1 Hz, 2H), 7.47 (d, J = 8.4 Hz, 
1H), 7.51-7.54 (m, 1H), 7.57-7.62 (m, 1H), 7.83 (dd, J = 8.1, 4.8 Hz, 2H), 8.09 (d, J = 8.4 Hz, 
1H). 13C NMR (62.9 MHz, CDCl3): δ = 21.1, (CH3), 119.9, (q, JF,C = 314.2 Hz, CF3), 120.0, 
126.6 (CH), 126.4 (C), 126.8, 126.9, 127.4, 127.5, 128.2, 128.5 (CH), 131.8, 132.4, 132.9, 
137.2, 140.9 (C).  IR (KBr): v = 3051, 3028, 2918, 2862 (m), 1513, 1498, 1425, 1415, 1336, 
1308, 1265, 1242, 1208, 1222, 1208, 1110, 1089, 1023, 1008, 958 (m), 807, 790, 783, 749, 
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722, 683 (s), 589, 573, 552 (m), cm−1. GC-MS (EI, 70 eV): m/z (%) = 366 (M+, 78), 275 (64), 
204 (27), 138 (25).  HRMS (EI, 70 eV): calcd for C18H13 F3O3S [M]+: 366.0559; found: 
366.0556.  Anal: C, 59.01; H, 3.58; found: C,59.02; H, 3.55. 
2-(Phenyl) naphthalen-1-yl trifluoromethanesulfonate (17c): Starting with 15 (258 mg, 
0.73 mmol), phenylboronic acid (89 mg, 0.73 mmol), Pd(PPh3)4 (42 
mg, 5 mol %), K3PO4 (232 mg, 1.1 mmol) and 1,4-dioxane (5 ml), 
following the general procedure B, 16c was isolated as a light yellow 
solid (197 mg, 77 %). m.p. 75-77 °C. 1H NMR (300 MHz, CDCl3): δ = 7.34-7.52 (m, 7H), 
7.55-7.61 (m, 1H), 7.81 (dd, J = 8.2, 3.4 Hz, 2H), 8.05 (d, J = 8.4 Hz, 1H). 19F NMR 
(282.4 MHz, CDCl3): δ = -73.9. 13C NMR (62.9 MHz, CDCl3): δ = 117.1 (q, JC,F = 316.2 Hz, 
CF3), 120.6, 126.1 (CH), 126.3 (C), 126.9, 127.0, 127.3, 127.4, 127.5, 127.6, 128.7 (CH), 
131.7, 133.0, 135.3, 140.9 (C). IR (KBr): v = 2931, 2865 (m), 1578, 1518, 1485, 1437, 1395, 
1321 (s), 1253, 1237, 1202, 1198, 1073, 958 (m), 837, 756, 719, 637 (s)  cm−1. GC-MS (EI, 
70 eV): m/z (%) = 352 (M+, 98), 275 (60). HRMS (EI, 70 eV): calcd for C17H11F3O3S [M]+: 
352.0412; found: 352.0411. Anal: C, 56.54 ; H, 3.45; found: C,56.52; H, 3.44.                                                  
2-(4-Chlorophenyl)naphthalen-1-yl trifluoromethanesulfonate (17d): Starting with 15 
(258 mg, 0.73 mmol), phenylboronic acid (114 mg, 0.73 mmol), 
Pd(PPh3)4 (42 mg, 5 mol %), K3PO4 (232 mg, 1.1 mmol) and 1,4-
dioxane (5 ml), following the general procedure B, 16d was 
isolated as a yellow solid (248 mg, 88 %). m.p. 82-84 °C. 1H 
NMR (300 MHz, CDCl3): δ = 7.38-7.41 (m, 5H), 7.51-7.56 (m, 1H), 7.57-7.63 (m, 1H), 7.84 
(dd, J = 8.1, 3.2 Hz, 2H), 8.09 (d, J = 8.4 Hz, 1H).  19F NMR (282.4 MHz, CDCl3): δ = -73.8. 
13C NMR (62.9 MHz, CDCl3): δ = 117.1 (q, JC,F = 263.0 Hz, CF3), 120.6 (CH), 126.3 (C), 
126.4, 126.9, 127.0, 127.1, 127.6, 127.8, 130.1  (CH), 130.6, 133.1, 133.6, 133.8, 140.8 (C). 
IR (KBr): v = 3073, 2954, 2922, 2852 (m), 1493, 1402, 1341, 1240, 1212, 1145, 1130, 1094 
(s), 1028, 1018, 1006 (m), 894, 864, 837, 811, 765, 750 (s), 734, 698, 680, 634, 626, 597, 
574, 549, 538 (m) cm−1. GC-MS (EI, 70 eV): m/z (%) = 386 (M+, 83), 253 (49), 218 (100), 
189 (23). HRMS (EI, 70 eV): calcd for C17H10ClF3O3S [M]+: 385.9985; found: 385.9988. 
Anal; C, 52.79; H, 2.61.  found: C, 52.76;  H, 2.58.                
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2-(4-Fluorophenyl)naphthalen-1-yl trifluoromethanesulfonate (17e): Starting with 15 
(258 mg, 0.73 mmol), p-fluorophenylboronic acid (102 mg, 0.73 
mmol), Pd(PPh3)4 (42 mg, 5 mol %), K3PO4 (232 mg, 1.1 mmol) 
and 1,4-dioxane (5 ml), following the general procedure B, 16c was 
isolated as a light yellow solid (229 mg, 85 %). m.p. 75-77 °C. 1H 
NMR (300 MHz, CDCl3): δ = 7.05-7.15 (m, 2H), 7.38-7.45 (m, 3H), 7.49-7.62 (m, 2H), 7.80-
7.59 (m, 2H), 8.09 (d, J = 8.4 Hz, 1H). 19F NMR (282.4 MHz, CDCl3): δ = -113.2, -74.0. 13C 
NMR (62.9 MHz, CDCl3): δ = 115.6 (d, JC,F = 21.4 Hz, CH), 117.1 (q, JC,F = 316.2 Hz, CF3), 
119.7 (C), 121.7, 127.3, 128.0 (CH), 128.2 (d, JF,C = 2.6 Hz, CH), 128.6, 131.4, 131.6 (CH), 
132.3, 132.4, 134.1, 141.9 (C), 161.9 (d, JF,C = 248.5 Hz, CF). IR (KBr): v = 2961, 1606 (w), 
1513, 1498 (m), 1405, 1341, 1201 (s), 1159 (m), 1132 (s), 1088, 1018, 1007 (m), 894 (s), 867 
(m), 816, 804 (s), 764 (m), 749 (s), 703, 683, 622, 598, 556, (m) cm−1. GC-MS (EI, 70 eV): 
m/z (%) = 370 (M+, 19), 237 (100), 209 (51), 183 (12). HRMS (EI, 70 eV): calcd for 
C17H10F4O3S [M]+: 370.0271; found: 370.0276. Anal; C, 55.14; H, 2.72.  found: C, 54.11; H, 
2.71.  
6.3.3 1,2-Diaryl usymmetricalnaphthalenes (18a-e) 
1-(4-Tert-butylphenyl)-2-(2-Methoxyphenyl)naphthalene (18a); Starting with 17a (100 
mg, 0.26 mmol), 4-tert-butylphenylboronic acid (40 mg, 0.31 mmol), 
Pd(PPh3)4 (15 mg, 5 mol %), K3PO4 (85 mg, 0.52 mmol) and 1,4-
dioxane (5 ml), following general procedure C, 18a was isolated as a 
viscous solid (124 mg, 66 %), 1H NMR (300 MHz, CDCl3): δ =  1.29 
(s, 9H, CH3), 3.51 (s, 3H, OCH3), 6.96-7.13 (m, 3H), 7.23-7.29 (m, 
2H), 7.33-7.37 (m, 1H), 7.39 (d, J = 8.63 Hz, 2H), 7.43 (d, J = 8.4 Hz, 
2H), 7.57 (d, J = 8.61 Hz, 2H), 7.76 (d, J = 8.3 Hz, 2H). 13C NMR (75.5 MHz, CDCl3): 
δ = 30.1 (3-CH3), 33.7 (C) 55.2 (OCH3), 116.6, 119.3, 120.3, 125.5, 125.6, 126.2, 127.3, 
128.0, 128.2, 128.5, 128.7, 129.3 (CH), 131.4, 131.7, 132.4, 132.7, 134.7, 136.5, 149.4, 156.4 
(C). IR (KBr): v = 3052, 3016, 2924, 2904, 2873 (m), 1625, 1577, 1551, 1493, 1454, 1413 
(s), 1296, 1267, 1243 (m), 1172, 1077, 1038, 897, 826, 812, 651, 624, 574 (s) cm−1. GC-MS 
(EI, 70 eV): m/z (%) = 366 (M+, 98), 335 (64), 278 (58). HRMS (EI, 70 eV): calcd for 
C27H26O [M]+: 366.4136; found: 366.4132.   
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2-(4-Methylphenyl)-1-(2, 5-dimethoxyphenyl) naphthalene (18b): Starting with 17b (100 
mg, 0.27 mmol), 2,5-dimethoxyphenylboronic acid (55 mg, 
0.30 mmol), Pd(PPh3)4 (16 mg, 5 mol %), K3PO4 (86 mg, 0.41 
mmol) and 1,4-dioxane (5 ml), following the general 
procedure B, 18a was isolated as a gummy solid (62 mg, 65 
%). 1H NMR (300 MHz, CDCl3): δ = 2.21 (s, 3H, CH3), 3.41 
(s, 3H, OCH3), 3.57 (s, 3H, OCH3), 6.56 (d, J = 2.7 Hz, 1H), 6.73-6.74 (m, 2H), 6.91 (d, J = 
7.8 Hz, 2H), 7.02 (d, J = 7.9 Hz, 2H), 7.29-7.32 (m, 1H), 7.34-7.41 (m, 1H), 7.48 (d, J = 8.4 
Hz, 2H), 7.81 (dd, J = 4.7, 4.4 Hz, 2H). 13C NMR (62.9 MHz, CDCl3): δ = 21.7 (CH3), 54.6 
(OCH3), 54.8 (OCH3), 110.8, 112.6, 117.1, 124.3, 125.1, 125.6, 126.6, 126.8 (CH), 127.1 
(2CH), 128.0 (2CH), 128.2 (CH), 128.3, 131.5, 131.7, 132.8, 134.7, 137.8, 138.2, 151.1, 
152.2 (C).  IR (KBr): v = 2934, 2872 (w), 1476, 1454, 1361, 1259 (m),  1166, 1043, 975, 843, 
834 (s), 742, 729, 708, 679, 647, 626 (m), 571, 542, 537 (s) cm−1. GC-MS (EI, 70 eV): m/z 
(%) = 354 (M+, 100), 323 (57), 263 (31), 216 (18). HRMS (EI, 70 eV): calcd for C25H22O2 
[M]+: 354.1623; found: 354.1621.  Anal: C, 84.72 H, 6.26; found: C, 84.69; H, 6.21.  
2-(Phenyl)-1-(2,methoxyphenyl) naphthalene (18c): Starting with 17c (100 mg, 0.28 
mmol), 2-methoxyphenylboronic acid (48 mg, 0.31 mmol), Pd(PPh3)4 
(16 mg, 5 mol %), K3PO4 (89 mg, 0.42 mmol) and 1,4-dioxane (5 
ml), following the general procedure B, 18c was isolated as a brown 
gummy solid (60 mg, 69 %). mp. 103-105 °C. 1H NMR (300 MHz, 
CDCl3): δ = 3.39 (s, 3H, OCH3), 6.82-7.21 (m, 4H), 7.34-7.45 (m, 6H), 7.47-7.54 (m, 1H), 
7.57-7.63 (m, 1H), 7.81-7.85 (m, 2H), 8.09 (d, J = 8.4 Hz, 1H). 13C NMR (62.9 MHz, 
CDCl3): δ = 54.6 (OCH3), 111.2, 120.7, 121.6 (CH), 124.6 (C), 127.0, 127.8, 128.1, 128.5, 
128.6, 129.2, 129.6 (CH), 129.8 (C), 130.2, 131.5, 131.8 (CH), 134.2, 142.6, 156.9 (C). GC-
MS (EI, 70 eV): m/z (%) = 310 (M+, 98), 279 (53), 233 (69). HRMS (EI, 70 eV): calcd for 
C23H18O [M]+: 310.1431; found: 310.1430.  Anal: C, 89.00, H, 5.85; found: C, 89.01; H, 5.81.  
2-(4-Chlorophenyl)-1-(3, 5-dimethylphenyl) naphthalene (18d). Starting with 17d (100 
mg, 0.26 mmol), 3,5-dimethylphenylboronic acid (44 mg, 0.29 
mmol), Pd(PPh3)4 (16 mg, 5 mol %), K3PO4 (83 mg, 0.39 mmol) and 
1,4-dioxane (5 ml), following the general procedure B, 18d was 
isolated as a reddish crystaline solid (64 mg, 72 %). m.p. 106-109 
°C. 1H NMR (300 MHz, CDCl3): δ = 2.19 (s, 6H, 2CH3) 6.71 ( brs, 2H), 6.84 (br s, 1H), 7.01-
7.12 (m, 4H), 7.29-7.35 (m, 1H), 7.38-7.44 (m, 2H), 7.42 (d, J = 8.4 Hz, 1H), 7.59 (d, J = 8.4 
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Hz, 2H). 13C NMR (62.9 MHz, CDCl3): δ = 21.3 (2 CH3), 125.1 (C), 125.7, 126.2, 127.1, 
127.4, 127.7, 127.8, 127.9, 128.4, 129.1, 131.3, 132.1, (CH), 132.1, 132.7, 132.8, 136.7, 
137.2, 138.1, 138.4, 140.6 (C). IR (KBr): v = 2978, 2853 (w), 1477, 1458, 1375, 1276, 1254 
(m), 1037, 1003, 987, 821, 834, 817 (s), 739, 721, 718, 673, 665, 608 (m), 573, 543, 537 (s) 
cm−1. GC-MS (EI, 70 eV): m/z (%) = 342 (M+, 100), 307 (58), 238 (36). HRMS (EI, 70 eV): 
calcd for C24H19Cl [M]+: 342.1271; found: 342.1269.  Anal: C, 84.26; H, 5.59; found: C, 
84.23; H, 5.58. 
2-(4-Fluorophenyl)-1-(m-tolyl) naphthalene (18e): Starting with 17e (200 mg, 0.54 mmol), 
3-methylphenylboronic acid (81 mg, 0.59 mmol), Pd(PPh3)4 (32 
mg, 5 mol %), K3PO4 (173 mg, 0.81 mmol) and 1,4-dioxane (5 ml), 
following the general procedure B, 18e was isolated as a solid (130 
mg, 77 %). m.p. 109-111 °C.  1H NMR (300 MHz, CDCl3): δ = 
2.23 (s, 3H, CH3), 6.75-6.91 (m, 4H), 7.00-7.05 (m, 3H), 7.10 (t, J = 7.4 Hz, 1H), 7.28-7.40 
(m, 2H), 7.43 (d, J = 8.6 Hz, 1H), 7.58 (d, J = 8.5 Hz, 1H), 7.81 (d, J = 8.2 Hz 2H). 19F NMR 
(282.4 MHz, CDCl3): δ = -116.6. 13C NMR (75.5 MHz, CDCl3): δ = 114.5 (d, JC,F = 21.3 Hz, 
CH), 125.8, 126.3, 126.9, 127.6, 127.8, 127.9, 128.1, 128.5, 131.5, 131.6, 132.1 (CH), 132.7, 
132.8, 137.2, 137.4, 137.9, 138.1 (d, JC,F = 3.3 Hz, C), 138.7 (C), 161.5 (d, JC,F = 245.6 Hz, 
CF). IR (KBr): v = 3050, 2920 (m), 2852 (w), 1601 (m), 1499 (s), 1457 (m), 1234 (w), 1218 
(s), 1155, 1092, 1023 (m), 962 (w), 863, 841 (m), 817, 803, 778, 743, 713, 693 (s), 653, 544 
(m) cm−1. GC-MS (EI, 70 eV): m/z (%) = 312 (M+, 100), 222 (55), 204 (07). HRMS (EI, 
70 eV): calcd for C23H17F [M]+: 312.1314; found: 312.1313.  
6.3.5 1, 2-Bis-arylnaphthalens (19a-c) 
1, 2-Bis(2-methoxyphenyl)naphthalen (19a): Starting with 15 (258 mg, 0.73 mmol), 2-
methoxyphenylboronic acid (244 mg, 1.61 mmol), Pd(PPh3)4 (42 
mg, 5 mol %), K3PO4 (464 mg, 2.19 mmol) and 1,4-dioxane (5 ml), 
following the general procedure B, 19a was isolated as a solid (154 
mg, 62 %). m.p = 105-107 C. 1H NMR (300 MHz, CDCl3): 
δ =  3.46 (s, 3H, OCH3), 3.52 (s, 3H, OCH3), 6.64-6.78 (m, 4H), 6.96-7.13 (m, 4H), 7.23-7.29 
(m, 1H), 7.33-7.38 (m, 1H), 7.43 (d, J = 8.4 Hz, 2H), 7.76 (d, J = 8.3 Hz, 2H). 13C NMR 
(75.5 MHz, CDCl3): δ = 55.1 (OCH3), 55.2 (OCH3), 110.1, 110.2, 111.1, 119.6, 119.7, 120.3, 
125.3, 125.7, 126.6, 127.1, 127.9, 128.1, 128.4, 128.6 (CH), 131.1, 131.4, 132.6, 132.8, 
135.2, 135.9, 156.4, 157.3 (C). IR (KBr): v = 3060, 3026, 2940, 2837 (m), 1605, 1597, 1581, 
1495, 1465, 1436, 1405 (s), 1343, 1296, 1270, 1254 (m), 1201, 1132, 1079, 1048, 1026, 1007, 
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895, 866, 812, 748, 708, 686, 634, 602, 588, 574 (s) cm−1. GC-MS (EI, 70 eV): m/z (%) = 341 
(M+, 98), 309 (57), 234 (47). HRMS (EI, 70 eV): calcd for C24H20O2 [M]+: 340.1534; found: 
340.1531.   
1, 2-Bis(4-methylphenyl)naphthalen (19b): Starting with 15 (258 mg, 0.73 mmol), p-
tolylboronic acid (219 mg, 1.61 mmol), Pd(PPh3)4 (42 mg, 5 mol 
%), K3PO4 (464 mg, 2.19 mmol) and 1,4-dioxane (5 ml), following 
the general procedure B, 19b was isolated as a white crystalline 
solid (177 mg, 79 %). m.p. 105-107 °C. 1H NMR (300 MHz, 
CDCl3): δ = 2.21, (s, 3H, CH3), 2.28, (s, 3H, CH3), 6.91 (d, J = 8.1 
Hz, 2H), 6.96-7.03 (m, 6H), 7.26-7.31 (m, 1H), 7.41 (d, J = 8.4 Hz, 2H), 7.54 (d, J = 8.4 Hz, 
1H), 7.80 (d, J = 8.3 Hz, 2H). 13C NMR (62.9 MHz, CDCl3): δ = 21.1, 21.3 (2CH3), 125.2, 
126.1, 126.9, 127.3, 127.8, 128.4, 128.5, 128.6, 130.1, 131.2 (CH), 132.7, 132.9, 135.6, 
136.1, 136.2, 137.5, 138.2, 139.2 (C). IR (KBr): v = 3051, 3028, 2918, 2862 (m), 1513, 1498, 
1425, 1415, 1336, 1308, 1265, 1242, 1208, 1222, 1208, 1110, 1089, 1023, 1008, 958 (m), 
807, 790, 783, 749, 722, 683 (s), 589, 573, 552 (m), cm−1. GC-MS (EI, 70 eV): m/z (%) = 308 
(M+, 100), 293 (34), 178 ( 27), 252 (15), 138 (25).  HRMS (EI, 70 eV): calcd for C24H20 [M]+: 
308.1559; found: 308.1558.  Anal: C, 93.46; H, 6.54; found: C, 93.41; H, 6.52.                                                 
1, 2-Bis(4-chlorophenyl)naphthalene (19c): Starting with 15 (258 mg, 0.73 mmol), p-
chloroboronic acid (251 mg, 1.61 mmol), Pd(PPh3)4 (42 mg, 5 mol %), 
K3PO4 (464 mg, 2.19 mmol) and 1,4-dioxane (5 ml), following the 
general procedure B, 19c was isolated as a white crystalline solid (239 
mg, 94 %). m.p. 170-180 °C. 1H NMR (300 MHz, CDCl3): δ = 6.95-
6.98 (m, 2H), 7.01-7.03 (m, 2H), 7.07-7.11 (m, 2H), 7.19-7.22 (m, 2H), 
7.30-7.35 (m, 1H), 7.38-7.44 (m, 2H), 7.56 (d, J = 8.5 Hz, 1H), 7.73 (d, J = 3.1 Hz, 1H), 7.89 
(d, J = 3.0 Hz, 1H).13C NMR (62.9 MHz, CDCl3): δ = 126.1, 126.4, 126.6 (CH), 127.4 (C), 
127.9, 128.1, 128.2, 128.3 (CH), 129.1 (C), 131.3 (CH), 132.4, 132.5 (C), 132.6 (CH), 132.9 
(C), 133.1 (CH), 136.3, 137.2, 140.1 (C). IR (KBr): v = 3050, 2923, 2852 (w), 1487, 1459, 
1395, 1374, 1259, 1209 (m), 1086, 1013, 961, 801, 840, 824, 810 (s), 752, 739, 730, 718, 679, 
657, 636, 608 (m), 573, 559, 540, 531 (s) cm−1. GC-MS (EI, 70 eV): m/z (%) = 348 (M+, 100), 
278 (58), 138 (36), 69 (26). HRMS (EI, 70 eV): calcd for C22H14Cl2 [M]+: 348.0467; found: 
348.0466.  Anal: C, 75.66; H, 4.04; found: C, 75.64; H, 4.01.  
6.3.6 Synthesis of 1-bromonaphth-2-ol (21). Compound 21 was prepared by the literature 
procedure Starting with 1-tetralone (20, (0.6 ml, 4.6 mmol), N-bromosuccinimide (NBS) (1.80 
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g, 10.1 mmol) and (PhCOO)2 (0.056 g, 5-mol %), following the general procedure G, 21 was 
isolated as colourless solid (0.81 g, 82 %). Spectral data was found in agrrement with the date 
reported in literature. 
6.3.7 1-Bromonaphthalen-2-yl trifluoromethanesulfonate (22). Starting with 21 (0.80 g, 
3.6 mmol) in CH2Cl2 (20 ml), pyridine  (0.5 ml, 7 mmol) and Tf2O (0.9 ml, 5.4 mmol) 
following the general procedure H, 22 was isolated as a light yellow oil (1.2 g, 92 %) Spectral 
data was found in agrrement with the date reported in literature.15 
6.3.8 1-Arylenaphthalen-2-yl trifluoromethanesulfonate (23a-b) 
1-p-Tolylnaphthalen-2-yl trifluoromethanesulfonate (23a). Starting with 22 (71 mg, 0.20 
mmol), p-tolylboronic acid (27 mg, 0.20 mmol), Pd(PPh3)4 (12 mg, 5 mol 
%), K3PO4 (64 mg, 0.30 mmol) and 1,4-dioxane (5 ml), following the 
general procedure B, 23a was isolated as a deep brown solid (54 mg, 73 
%). m.p. 70-72 °C. 1H NMR (300 MHz, CDCl3): δ = 2.33 (s, 3H, CH3), 
7.21 (d, J = 8.2 Hz, 2H), 7.24 (d, J = 8.4 Hz, 1H), 7.39-7.46 (m, 1H), 7.49-
7.56 (m, 1H), 7.68 (d, J = 8.4 Hz, 2H), 7.76 ( d, J = 8.5 Hz, 2H), 8.15 (d, J = 8.5 Hz, 1H). 19F 
NMR (282.4 MHz, CDCl3): δ = -73.2. 13C NMR (75.5 MHz, CDCl3): δ = 13C NMR 
(62.9 MHz, CDCl3): δ = 21.1, (CH3), 119.9, (q, JF,C = 314.2 Hz, CF3), 119.8, 126.8, 127.3, 
127.6, 127.7, 128.1 (CH), 128.3 (C), 129.1, 130.6 (CH), 132.8, 132.6, 133.4, 138.3, 144.3 (C). 
IR (KBr): v = 3019, 2927, 2869 (m), 1541, 1498, 1438, 1423, 1301, 1285, 1245, 1211, 1108, 
1093, 1073, 967 (m), 817, 793, 771, 758, 712, 653 (s), 574, 542 (m), cm−1. GC-MS (EI, 
70 eV): m/z (%) = 366 (M+, 98), 275 (57), 217 (44), 138 (37). HRMS (EI, 70 eV): calcd for 
C18H13F3O3S [M]+: 366.0519; found: 366.0511. Anal: C, 59.01; H, 3.58; found: C, 59.02; H, 
3.55.  
1-(5-Chloro-2-methoxyphenyl)naphthalen-2-yl trifluoromethanesulfonate (23b). Starting 
with 22 (71 mg, 0.20 mmol), 5-chloro-2-methoxyphenylboronic acid 
(37 mg, 0.20 mmol), Pd(PPh3)4 (12 mg, 5 mol %), K3PO4 (64 mg, 0.30 
mmol) and 1,4-dioxane (5 ml), following the general procedure B, 23b 
was isolated as a white solid (50 mg, 60 %). m.p. 75- 77 °C. 1H NMR 
(300 MHz, CDCl3): δ = 3.69 (s, OCH3), 6.79 (d, J = 8.4 Hz, 2H), 6.98 
(d, J = 8.2 Hz, 1H), 7.10-7.11 (m, 1H), 7.16-7.21 (m, 2H), 7.33-7.47 (m, 2H), 7.80-7.89 (m, 
1H). 19F NMR (282.4 MHz, CDCl3): δ = -74.5. 13C NMR (62.9 MHz, CDCl3): δ = 54.7 
(OCH3), 117.5 (q, JF,C = 316.2 Hz, CF3), 120.1, 121.3 (CH), 126.1, 126.4 (C), 127.2, 127.6, 
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128.5, 128.8, 129.2, 130.0, 131.6 (CH), 132.7, 134.0, 137.8, 142.3, 155.1 (C). IR (KBr): v = 
3014, 2941, 2872 (w) 1655, 1572, 1581, 1466, 1436, 1405, 1361, 1343, 1270, 1254 (m), 
1200, 1132, 1079, 1048, 1026, 1007, 895, 866, 811, 748 (s), 708, 686, 634, 602, 588, 574 (m) 
cm−1. GC-MS (EI, 70 eV): m/z (%) = 416 (M+, 81), 274 (76), 267 (43), 141 (29). HRMS (EI, 
70 eV): calcd for C18H12ClF3O4S [M]+: 416.0135; found: 416.0131.  Anal; C, 51.87; H, 2.90; 
found; C, 51.86; H, 2.88 
Synthesis of 1-(4-Bromo-1-hydroxynaphthalen-2-yl)ethanone (25). Starting with 2-acetyl-
3,4-dihydronaphthalen-1(2H)-one (24) (3.00 g, 13.7 mmol), N-
bromosuccinimide (NBS) (5.40 g, 30.2 mmol) and (PhCOO)2 (0.17 g, 5 
mol %), following the general procedure G, 25 was isolated as  green 
crystalline solid. m.p. 124-126 °C. 1H NMR (300 MHz, CDCl3):  = 
2.59 (s, 3H, CH3), 7.47-7.53 (m, 1H), 7.63-7.68 (m, 1H), 7.87 (s, 1H), 8.03 (d, J = 8.4 Hz, 
1H), 8.38 (d, J = 8.3 Hz, 1H), 13.83 (s, OH). 13C NMR (75.5 MHz, CDCl3):  = 26.8 (CH3), 
111.1, 113.9 (C), 124.8, 126.41 (CH), 126.7 (C), 127.1, 128.2, 131.2 (CH), 135.7, 161.9, 
203.3 (C). IR (KBr): v = 3130, 3071, 3033 (m), 1731, 1712, 1620, 1614, 1574, 1565, 1502, 
1447, 1406, 1363, 1314, 1265, 1236, 1211, 1137 (s), 1082, 1025, 979, 871, 862, 837, 862, 
837 (m), 754, 720, 686, 643, 588, 565 (s) cm−1. GC-MS (EI, 70 eV): m/z (%) = 264 (M+, 100), 
251 (76), 195 (20), 114 (23). HRMS (EI, 70 eV): calcd for C12H9BrO2 [M]+: 263.9781; found: 
263.9778. Anal: C, 54.37; H, 3.42; found: C, 54.31; H, 3.41.  
6.3.9 2-Acetyl-4-(4-aryl)naphthalen-1-yl trifluoromethanesulfonate (27) 
2-Acetyl-4-Bromonaphthalen-1-yl trifluoromethanesulfonate (27). Starting with 25 (2.00 
g, 7.54 mmol) in CH2Cl2 (25 ml), pyridine  (1.5 ml, 20 mmol) and 
Tf2O (1.8 ml, mmol) following the general procedure H,  27 was 
isolated as a light green oil (2.75 g, 88 %). 1H NMR (300 MHz, 
CDCl3):  = 2.59 (s, 3H, CH3), 7.46-7.51 (m, 1H), 7.62-7.71 (m, 2H), 
7.92 (s, 1H), 8.11 (d, J = 8.4 Hz, 1H). 19F NMR (282.4 MHz, CDCl3): δ = -72.7. 13C NMR 
(75.5 MHz, CDCl3):  = 29.6 (CH3),  117.5 (q, JC,F = 321 Hz, CF3), 121.7 (C), 122.18 (CH), 
126.5, 126.6 (C), 127.0, 128.1, 129.2, 130.3 (CH), 133.3, 140.3 195.6 (C). IR (KBr): v = 
3076, 3002, 2962, 2929 (m), 1699, 1620, 1594, 1494, 1426, 1403 (s), 1370, 1351, 1318, 1266, 
1243 (m), 1203, 1130, 1171, 1037, 867, 818, 760, 720, 647, 629, 603, 571, 551 (s) cm-1. GC-
MS (EI, 70 eV): m/z (%) =  396 (M+, 97), 265 (95), 248 (20), 237 (73), 128 (36). HRMS (EI, 
70 eV): calcd for C13H8BrF3O4S [M]+: 395.9273; found: 395.9269. Anal: C, 39.31; H, 2.02; 
found: C, 39.29; H, 2.01. 
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2-Acetyl-4-(4-Methoxyphenyl)naphthalen-1-yl trifluoromethanesulfonate (28a). Starting 
with 27 (79 mg, 0.20 mmol), 4-methoxyphenylboronic acid (30 mg, 
0.20 mmol), Pd(PPh3)4 (12 mg, 5 mol %), K3PO4 (64 mg, 0.30 mmol) 
and 1,4-dioxane (5 ml), following the general procedure B, 28a was 
isolated as a light brown oil (53 mg, 62 %). 1H NMR (300 MHz, 
CDCl3):   = 2.64 (s, 3H, CH3), 3.83 (s, 3H, OCH3), 6.96-7.01 (m, 
2H), 7.18 (s, 1H), 7.31-7.34 (m, 1H), 7.50-7.55 (m, 2H), 7.59-7.64 
(m, 1H), 7.87 (d, J = 8.5 Hz, 1H), 8.16 (d, J = 8.5 Hz, 1H).  19F NMR 
(282.4 MHz, CDCl3): δ = -72.8. 13C NMR (75.5 MHz, CDCl3):  = 29.7 (CH3), 55.4 (OCH3),  
114.1 (CH), 117.5 (q, JC,F = 321 Hz, CF3), 122.5, 125.0, 126.6 (CH), 126.9 (C), 128.1, 128.7 
(CH), 129.5, 130.7 (C), 131.0 (CH),  134.5, 140.9, 141.1, 159.6 (C), 198.3 (CO). IR (KBr): 
v = 3073, 3003, 2957, 2929, 2838 (m), 1697, 1607, 1572, 1515, 1499, 1456, 1423, 1404, 1366 
(s), 1290, 1256 (w), 1244, 1204, 1177, 1149, 1134, 1028 (s), 978, 943, 937, 886 (m), 831, 
793, 764, 721, 707, 636, 604, 588, 574 (s) cm-1. GC-MS (EI, 70 eV): m/z (%) = 424 (M+, 81), 
291 (98), 277 (17), 263 (36), 235 (12), 149 (29). HRMS (EI, 70 eV): calcd for C20H15F3O5S 
[M]+: 424.0678; found: 424.0668  Anal: C, 56.61; H, 3.56; found: C, 56.59; H, 3.54.  
2-Acetyl-4-(4-Chlorophenyl)naphthalen-1-yl trifluoromethanesulfonate (28b). Starting 
with 27 (79 mg, 0.20 mmol), 4-chlorophenylboronic acid (31 mg, 
0.20 mmol), Pd(PPh3)4 (12 mg, 5 mol %), K3PO4 (64 mg, 0.30 mmol) 
and 1,4-dioxane (5 ml), following the general procedure B, 28b was 
isolated as a semisolid (74 mg, 86 %). 1H NMR (300 MHz, CDCl3):  
 = 2.61 (s, 3H, CH3), 6.91-6.97 (m, 2H), 7.13 (s, 1H), 7.28-7.332 (m, 
1H), 7.47-7.52 (m, 2H), 7.56-7.61 (m, 1H), 7.81 (d, J = 8.4 Hz, 1H), 
8.14 (d, J = 8.4 Hz, 1H). 19F NMR (282.4 MHz, CDCl3): δ = -72.3. 
13C NMR (75.5 MHz, CDCl3):  = 29.4 (CH3), 113.8 (CH), 116.9 (q, JC,F = 321 Hz, CF3), 
121.7, 121.8, 121.4 (CH), 125.6 (C), 127.7, 127.9 (CH), 128.2, 129.8 (C), 131.0 (CH),  133.7, 
140.0, 141.1, 158.9 (C), 198.0 (CO). IR (KBr): v = 3067, 3023, 2975, 2883 (m), 1687, 1636, 
1552, 1423, 1404, 1386 (s), 1266 (w), 1231, 1209, 1176, 1141 (s), 972, 934, 874 (m), 831, 
773, 761, 709, 570 (s) cm-1. GC-MS (EI, 70 eV): m/z (%) = 428 (M+, 98), 317 (76), 279 (37), 
168 (09). HRMS (EI, 70 eV): calcd for C19H12ClF3O4S [M]+: 428.0156; found: 428.0154. 
Anal: C, 53.22; H, 2.82; found: C, 53.19; H, 2.79.  
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6.3.10 1-(1,4-Diarylnaphthalen-2-yl)ethanone (29) 
1-(1,4-Di-p-tolylnaphthalen-2-yl)ethanone (29a); Starting with 27 (79 mg, 0.20 mmol), p-
tolylboronic acid (60 mg, 0.44 mmol), Pd(PPh3)4 (12 mg, 5 mol %), 
K3PO4 (127 mg, 0.60 mmol) and 1,4-dioxane (5 ml), following the 
general procedure B, 29a was isolated as a light yellow gummy solid (60 
mg, 85 %). 1H NMR (300 MHz, CDCl3):  = 2.1 (s, 3H, CH3), 2.3 (s, 
3H, CH3), 2.4 (s, 3H, CH3), 7.21-7.27 (m, 6H), 7.33-7.41 (m, 4H), 7.50 
(s, 1H), 7.63-7.72 (m, 1H), 7.88-7.91 (m, 1H). 13C NMR (75.5 MHz, 
CDCl3):  = 21.2, 21.3, 30.8 (CH3), 125.1, 126.2, 126.4, 127.1, 127.6, 
129.1, 129.2, 129.9, 130.6 (CH), 132.5, 132.8, 135.3, 137.1, 137.3, 137.6, 137.7, 137.9, 140.1 
(C), 204.9 (CO). IR (KBr): 3022, 2921, 2865 (w), 1711 (s), 1591, 1511 (w), 1485, 1378, 1367 
(m), 1241, 1220, 1192 (s), 1099, 1020, 926 (m), 814, 746 (s), 687, 595 (m) cm-1. GC-MS (EI, 
70 eV): m/z (%) = 350 (M+, 99), 259 (66), 91 (07); Anal: C, 89.11; H, 6.33; found: C, 89.09; 
H, 6.31; HRMS (EI, 70 eV): calcd for C26H22O [M]+: 350.1745; found: 350.1741. 
1-(1,4-Bis(2-chlorophenyl)naphthalen-2-yl) ethanone (29b). Starting with 27 (79 mg, 0.20 
mmol), 2-chlorophenylboronic acid (69 mg, 0.44 mmol), Pd(PPh3)4 (12 mg, 
5 mol %), K3PO4 (127 mg, 0.60 mmol) and 1,4-dioxane (5 ml), following 
the general procedure B, 29b was isolated as a light yellow gummy solid 
(229 mg, 85 %). 1H NMR (300 MHz, CDCl3):  = 2.1 (s, 3H, CH3), 7.17-
7.21 (m, 1H), 7.31-7.33 (m, 5H), 7.38-7.39 (m, 2H), 7.41-7.43 (m, 2H), 
7.50 (s, 1H), 7.59 (dd, J = 7.1, 1.5 Hz, 1H), 7.80 (dd, J = 7.2, 1.5 Hz, 1H). 
13C NMR (75.5 MHz, CDCl3):  = 29.7 (CH3), 120.6, 124.1, 124.8, 125.9, 
126.4, 126.7, 127.1, 127.3, 127.8, 128.6, 128.8, 128.9, 129.4 (CH), 131.2, 
131.4, 133.3, 133.5, 135.6, 136.2, 138.2, 139.0, 140.5 (C), 202.3 (CO). IR (KBr): v = 3063 
(w), 2929, 2857 (w), 1714 (m), 1588 (w), 1498, 1362, 1353, 1244 (m), 1218, 1192, 1087 (s), 
1013, 907 (m), 823, 764, 740, 690 (s) cm-1. GC-MS (EI, 70 eV): m/z (%) = 390 (M+, 99), 347 
(23), 279 (61). Anal: C, 73.67; H, 4.12; found: C, 73.64; H, 4.09; HRMS (EI, 70 eV): calcd 
for C26H16Cl2O [M]+: 390.0651; found: 390.0646.  
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6.4 Synthesis of Heteroaryl-Fused Benzopyranone Analagues and Arylated 
Naphthaquinones.: 
6.4.1 3-Bromo-2-methoxycarbonylbenzo[b]thiophene (33): 
General procedure I for the synthesis of 33; To a cold solution (ice bath) of o-
nitrobenzonitrile (0.60 g, 4 mmol in DMF, 10 ml) and KOH (3.00 g, aqueous), was added 
methyl thioglycolate (0.50 g, 4.0 mmol) dropwise. The mixture was stirred at ice bath 
temprature for 1 h and poured into ice water and extracted with DCM to obtain the crude 
product. This crude product was added to the stirring solution of anhydrous CuBr2 (4.0 mmol), 
tert-butyl nitrite (5.0 mmol) in acetonitrile (10 ml). During this addition the reaction solution 
turned completely black. The reaction solution was then poured into 200 ml of 20 % HCl 
(aqueous) and extracted with 200 ml of ether, and the organic layer was washed once with 
200 ml water. The resulting ether solution was dried over Mg2SO4 and the ether was removed 
under reduced pressure, purified through chromatography eluating with heptan/EtOAc to 
obtain the product 33. 
 
 3-Bromo-2-methoxycarbonylbenzo[b]thiophene (33): Starting with 32 (0.50 g, 2.4 mmol), 
tert-butyl nitrite (0.30 g, 6.5 mmol), CuBr2 (0.60 g, 2.9 mmol)  
following the general procedure I, compound 33 was obtained as 
yellowish solid (0.52 g, 80 %). 1H NMR (300 MHz, CDCl3):  = 
3.78 (s, OCH3, 3H), 7.89-7.93 (m, 1H), 7.73-7.79 (m, 1H), 7.38-
7.48 (m, 2H); 13C NMR: (75.5 MHz, CDCl3):  = 52.5 (OCH3), 115.1, 127.5 (C), 122.6, 
125.3, 125.6, 128.1 (CH), 139.3, 138.6 (C), 161.8 (CO); IR (KBr): v = 3420 (s), 3056, 2922, 
(m), 1718 (s), 1532, 1486, 1426 (m), 1269, 1232, 1173, 1056 (s), 1028, 826 (m), 756, 752, 
736, 692, 609 (s) cm-1; GC-MS: (EI, 70 eV): m/z (%): (M+, 272 (87), 241 (100), 213 (21), 132 
(50);  Anal. Calcd for  C10H7BrO2S: C, 44.11; H, 2.57; Found:  C, 44.07; H, 2.60; HRMS: (EI, 
70 eV): calcd for C10H7BrO2S [M+H]+: 271.9402; found: 271.9404. 
6.4.2 3-Phenyl-2-methoxycarbonylbenzo[b]thiophene (35a-h) 
 
3-Phenyl-2-methoxycarbonylbenzo[b]thiophene (35a); Starting with 33 (100 mg, 0.36 
mmol), phenylboronic acid (52 mg, 1.2 equiv.), Pd(PPh3)4 (21 mg, 5 
mol %), K3PO4 (114 mg, 1.5 equiv.) and 1,4-dioxane (5 ml), following 
the general procedure B, 35a was obtained as white solid product (72.58 
mg, 74 %).  1H NMR (300 MHz, CDCl3):  = 3.78 (s, 3H, OCH3), 7.79-
7.82 (m, 1H), 7.43-7.83 (m, 1H), 7.38-7.42 (m, 4H), 7.25-7.34 (m, 3H); 13C NMR: (75.5 
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MHz, CDCl3):  = 52.1 (OCH3), 122.5, 124.8, 125.4, 127.31, 128.1, 129.6 (CH), 128.9, 
134.5, 140.1, 140.4, 144.2 (C), 161.8 (CO); IR (KBr): v = 3400 (s), 3056, 2922, (m), 1718 (s), 
1532, 1486, 1426 (m), 1269, 1232, 1173, 1056 (s), 1028, 826 (m), 756, 752, 736, 692, 609 (s)  
cm-1; GC-MS: (EI, 70eV): m/z (%) = (M+, 268 (100), 237 (90),  208 (26), 165 (34); Anal. 
Calcd for C10H8BrO2S: C, 71.64; H, 4.47; S, 11.94; Found: C, 70.2; H, 4.39; S, 11.81; HRMS: 
(EI, 70 eV): calcd for C16H12O2S [M+]: 268.0552; found: 268.0553. 
3-(4-Chlorophenyl)-2-methoxycarbonylbenzo[b]thiophene (35b); Starting with 33 (100 
mg, 0.36 mmol), 4-chlorophenylboronic acid (68 mg, 1.2 equiv.), 
Pd(PPh3)4 (21 mg, 5 mol %), K3PO4 (114 mg, 1.5 equiv.) and 1,4-
dioxane (5 ml), following the general procedure B, 35b was obtained as 
yellow powder product (86.2 mg, 78 %). 1H NMR (300 MHz, CDCl3):  
 = 3.68 (s, OCH3, 3H), 7.79-7.82 (m, 1H), 7.73-7.45 (m, 4H), 7.24-
7.31 (m, 3H);  13C NMR (75.5 MHz, CDCl3):  = 52.2 (OCH3), 122.5, 124.9, 125.1, 127.3, 
128.3, 131.1 (CH), 132.8, 134.1, 139.7, 140.4, 142.7 (C), 162.7 (CO); IR (KBr): v = 3411, 
2960, 2949 (s), 1713, 1531, 1482, 1434 (s), 1348, 1318, 1299 (m), 1271, 1237, 1173, 1081, 
1059, 1013, 985 (s), 949, 910, 860 (m), 844, 809, 798, 757, 738, 708 (s) cm-1; GC-MS: (EI, 
70eV): m/z (%) = (M+, 302 (100), 271 (53), 236 (41), 208 (28); Anal. Calcd for C16H11ClO2S: 
C, 63.15; H, 3.61, Found: C, 63.28; H, 3.27; HRMS: (EI, 70 eV): calcd for C16H11ClO2S [M+]: 
302.0162; found: 302.0166. 
3-(4-Tolyl)-2-methoxycarbonylbenzo[b]thiophene (35c); Starting with 33 (100 mg, 0.36 
mmol), 4-methylphenylboronic acid (59 mg, 1.2 equiv), Pd(PPh3)4 (21 
mg, 5 mol %), K3PO4 (114 mg, 1.5 equiv.) and 1,4-dioxane (5 ml), 
following the general procedure B, 35c was obtained as colorless solid 
(79.1 mg, 76 %). 1H NMR (300 MHz, CDCl3):  = 2.4 (s, 3H, CH3), 
3.87 (s, OCH3, 3H), 7.73-7.42 (m, 1H), 7.72-7.47 (m, 4H), 7.24-7.31 
(m, 3H); 13C NMR (75.5 MHz, CDCl3):  = 28.6 (CH3), 51.5 (OCH3), 121.6, 123.7, 125.1, 
126.3, 127.4, 132.1 (CH), 132.2, 133.8, 139.7, 140.7, 141.8 (C), 162.2 (CO); IR (KBr): v = 
3433, 3062, 2995, 2949 (s), 1720, 1561, 1516, 1488 (s), 1433, 1385 (m), 1322, 1305, 1271, 
1242, 1230, 1154, 1114, 1093, 1086, 1072, 1056 (s), 982, 922, 906 (m), 800, 784, 750, 735, 
723, 696, 677, 649 (s) cm-1; GC-MS: (EI, 70eV): m/z (%) = (M+, 282 (100), 251 (56), 236 
(47), 221 (21), 208 (31); Anal. Calcd for  C17H14O2S: C, 72.34; H, 4.91; Found:  C, 72.21; H, 
4.87; HRMS: (EI, 70 eV): calcd for C17H14O2S: [M+]: 282.0756; found: 282.0759. 
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3-(2-Methoxyphenyl)-2-methoxycarbonylbenzo[b]thiophene (35d); Starting with 33 (100 
mg, 0.36 mmol), 2-methoxyphenylboronic acid (65 mg, 1.2 equiv), 
Pd(PPh3)4 (21 mg, 5 mol %), K3PO4 (114 mg, 1.5 equiv.) and 1,4-
dioxane (5 ml), following the general procedure B, 35e was obtained as 
solid (83.6 mg, 76 %). 1H NMR (300 MHz, CDCl3):  = 3.69 (s, 3H, 
OCH3, 3H), 3.86 (s, OCH3, 3H), 7.86 (dd, J = 7.6, 3.4 Hz, 1H), 7.69 (dd, J = 7.3, 3.3 Hz, 1H), 
7.34-7.41 (m, 2H), 6.26-6.37 (m, 4H); 13C NMR (75.5 MHz, CDCl3):  = 51.2 (OCH3),  54.1 
(OCH3), 114.1, 114.3, 121.6, 125.6, 125.9, 127.89, 128.2, 129.8 (CH), 128.8, 132.1, 137.3, 
138.2, 141.2, 159.6, (C), 162.3 (CO); IR (KBr): v = 2951, 2923, 2852 (s), 1723, 1615, 1409 
(s), 1276, 1194, 1194, 1152, 1131 (s), 990, 957, 832, 817 (m), 754, 731, 722, 652, 546 (s) cm-
1; GC-MS: (EI, 70eV): m/z (%) = (M+, 298 (100), 267 (47), 203 (14);  HRMS: (EI, 70 eV): 
calcd for C17H14O3S [M]+: 298.0727;  found: 298.0731. 
 
3-(2,5-Dimethoxyphenyl) -2-methoxycarbonylbenzo[b]thiophene (35e); Starting with 33 
(100 mg, 0.36 mmol), 2,5-dimethoxyphenylboronic acid (75 mg, 0. 1.2 
equiv), Pd(PPh3)4 (21 mg, 5 mol %), K3PO4 (114 mg, 1.5 equiv.) and 
1,4-dioxane (5 ml), following the general procedure B, 35f was 
obtained as brown solid (92 mg, 76 %). 1H NMR (300 MHz, CDCl3):  
= 3.69 (s, 6H, OCH3), 3.87 (s, OCH3, 3H,), 7.88 (dd, J = 7.3, 3.3 Hz, 1H), 7.17 (dd, J = 6.7, 
3.2 Hz, 1H), 7.37-7.45 (m, 2H), 6.37-6.43 (m, 3H); 13C NMR (75.5 MHz, CDCl3):  = 51.4 
(OCH3), 54.2 (OCH3), 114.1, 114.3, 121.6, 125.6, 125.9, 128.2, 129.8 (CH), 128.8, 132.3, 
137.6, 138.3, 141.7, 159.8, 160.7 (C), 162.1 (CO); IR (KBr): v = 1733, 1615, 1426 (s), 1226, 
1196, 1184, 1156, 1121 (s), 990, 907, 837, 807 (m), 750, 736, 742, 622, 556 (s) cm-1; GC-
MS: (EI, 70eV): m/z (%) = (M+, 328 (100), 305 (91), 285 (16), 257 (12), 208 (21); Anal. 
Calcd for C, 65.84; H, 4.91; S, 9.76, Found: C, 65.13; H, 4.79; S, 9.19; HRMS: (EI, 70 eV): 
calcd for C18H16O4S[M]+: 328.0831; found: 328.0828. 
3-(5-Chloro-2-methoxyphenyl)-2-methoxycarbonylbenzo[b]thiophene (35f); Starting with 
33 (100 mg, 0.36 mmol), 2-methoxy-5-chlorophenylboronic acid (80 
mg, 0. 1.2 equiv), Pd(PPh3)4 (21 mg, 5 mol %), K3PO4 (114 mg, 1.5 
equiv.) and 1,4-dioxane (5 ml), following the general procedure B, 35g 
was obtained (76 mg, 62 %). 1H NMR (300 MHz, CDCl3):  = 3.68 (s, 
OCH3, 3H), 3.86 (s, OCH3, 3H), 7.81 (dd, J = 8.1, 3.4 Hz, 1H), 7.72 (dd, J = 8.3, 3.3 Hz, 1H), 
7.35-7.43 (m, 2H), 7.11 (d, J = 2.6 Hz, 1H), 6.83 (dd, 6.6, 2.6 Hz, 1H), 6.65 (d, J = 8.6 Hz, 
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1H); 13C NMR (75.5 MHz, CDCl3):  = 55.6 (OCH3), 113.2, 114.0, 121.2, 124.6, 126.3, 
128.7, 133.4 (CH), 128.2, 131.2, 135.9, 137.2, 137.6, 143.7, 155.3 (C), 161.7 (CO); IR (KBr): 
v = 2956, 2847 (s), 1747, 1675, 1590 (s), 1366, 1276, 1147, 1126 (w), 987, 947, 876, 827 (m), 
755, 726, 621, 566 (s) cm-1; GC-MS (EI, 70eV): m/z (%) = (M+, 332 (100), 272 (16), 251 
(12); Anal. Calcd for C, 61.35; H, 3.94; Found: C, 61.23; H, 3.76;  HRMS: (EI, 70 eV): calcd 
for C17H13O3S[M]+: 332.0342; found: 332.0346. 
3-(Naphthalen-2-yl)-2-methoxycarbonylbenzo[b]thiophene (35h); Starting with 33 (100 
mg, 0.36 mmol), 2-naphthylboronic acid (74 mg, 1.2 equiv,), Pd(PPh3)4 
(21 mg, 5 mol %), K3PO4 (114 mg, 1.5 equiv.) and 1,4-dioxane (5 ml), 
following the general procedure B, 35h was obtained as colorless solid 
(75.1 mg, 64 %). 1H NMR (300 MHz, CDCl3):  = 3.68 (s, OCH3, 3H), 
7.87 (dd, J = 8.3, 2.8 Hz, 2H), 7.79-7.82 (m, 3H), 7.38-7.52 (m, 5H), 7.23-7.31 (m, 1H ); 13C 
NMR (75.5 MHz, CDCl3):  = 51.2 (OCH3), 121.5, 123.8, 124.3, 125.1, 125.3, 126.2, 126.5, 
126.8, 126.8, 127.1, 127.5 (CH). 131.1, 131.9, 132.1, 139.2, 139.3, 143.2 (C), 161.9 (CO); IR 
(KBr): v = 3419, 2985, 2922, 2852 (s), 1718, 1598, 1523, 1434, 1274, 1267, 1228 (s), 1199, 
1153, 1121, 1080, 1056, 1015 (m), 985, 963, 949, 907, 892, 865 (w), 817, 794, 778, 754, 748, 
736, 718, 660, 621, 604, 556 (s) cm-1; GC-MS: (EI, 70eV): m/z (%) = (M+, 318 (100), 287 
(61), 258 (33), 215 (14); Anal. Calcd for C, 75.45; H, 4.43; Found: C, 75.13; H, 4.12; HRMS: 
(EI, 70 eV): calcd for C20H14O2S[M]+: 318.0709; found: 318.0713. 
6.4.3 6H-[1]Benzothieno[2,3-C]chromen-6-one (36);  
General procedure J; To a CH2Cl2 solution of 35 BBr3 was added at 0 °C. The solution was 
stirrered and allowed to warm to room temp during 2 h. To the solution was added an aqueous 
solution of KO-tert-BuOH (0.1 M) and the solution was stirred for 15 min. The organic and 
the aqueous layer were separated and the latter was extracted with CH2Cl2. The combined 
organic portion was dried over (Na2SO4), filtered and the filtrate was concentrated in vacuo. 
The product was purified by chromatography (silica gel, heptane/EtOAc). 
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6H-[1]Benzothieno[2,3-C]chromen-6-one (36a); Starting with 35e (75 mg, 0.25 mmol), 
BBr3 (1.5 ml, 4 equiv.), Pot. tert-butoxide (0.1 M, aqueous sol), following 
the general procedure J, 36a was obtained as white crystalline solid (37.8 
mg, 60 %).  1H NMR (300 MHz, CDCl3):  = 8.57-8.61 (m, 1H), 8.43-8.46 
(m, 1H), 7.95-7.98 (m, 1H), 7.50-7.58 (m, 2H), 7.46-7.48 (m, 2H), 7.36- 
7.41 (m, 1H); 13C NMR (75.5 MHz, CDCl3):  = 118.1, 118.3, 123.4, 123.9, 124.7, 125.6, 
125.9, 128.2 (CH), 126.2, 129.8, 135.1, 138.6, 143.6, 152.7, 157.9 (CO); IR (KBr): v = 1734 
(s), 1572, 1466, 1432 (m), 1289, 1221, 1193, 1034 (s), 1022, 831 (m), 776, 732, 721, 682, 619 
(s) cm-1; GC-MS: (EI, 70 eV): m/z (%) = (M+, 252.9 (100), 224 (25), 195 (18), 152 (17); Anal. 
Calcd for C15H8O2S; C, 71.41; H, 3.20; S, 12.71; Found: C, 71.45; H, 3.19; S, 11.97; HRMS: 
(EI, 70 eV): calcd for C15H8O2S[M+]: 252.0245; found: 252.0241. 
2-Chloro-6H-[1]Benzothieno[2,3-C]chromen-6-one (36b); Starting with 35g (50 mg, 0.180 
mmol), BBr3 (1.5 ml, 4 equiv.), Pot. tert-butoxide (0.1 M, aqueous sol), 
following the general procedure J, 36a was obtained as white powder (21.5 
mg, 50 %).  1H NMR (300 MHz, CDCl3):  = 8.31 (d, J = 8.3 Hz, 1H), 7.98 
(d, J = 3.1 Hz, 1H), 7.83 (d, J = 8.2 Hz, 1H), 7.30-7.46 (m, 4H); 13C NMR 
(75.5 MHz, CDCl3):  = 113.8, 114.6, 121.7, 125.2, 126.8, 129.3, 133.8 
(CH), 129.1, 131.7, 136.3, 137.5, 138.3, 144.5, 156.2, 162.3 (CO);  IR (KBr): v = 1720, 1687, 
1576 (s), 1349, 1256, 1172, 1186 (s), 982. 347 (m), 751, 734, 614, 586 (s) cm-1; GC-MS: (EI, 
70eV): m/z (%) = (M+, 286 (100), 25 (31); Anal. Calcd for C, 62.83; H, 2.46; Cl, 12.36; 
Found: C, 61.88; H, 2.34; HRMS: (EI, 70 eV): calcd for C15H7ClO2S[M+]: 285.9945; found: 
285.9941. 
6.4.4 Synthesis of 2,3-dibromonaphthalene-1,4-diol (38); 
General procedure K for the synthesis of 38; A suspension of 37 (2.0 g) in 30 ml of diethyl 
ether was shaken in a separatory funnel with a freshly prepared solution of Na2S2O4 (5.00 g) 
in 10 ml of water. After the mixture was shaken for 1h, the organic layer was separated, 
washed with brine (2 x 25 ml), dried over Na2S04, and then concentrated on rot.vap to give of 
38 as a brown solid (2.2 g, 90 %). 
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Synthesis of 2,3-Dibromonaphthalene-1,4-diol (38); Starting with 37 (2.0 g, 1.0 equiv.), 
Na2S2O4 (5.00 g), following the general procedure K, compound 38 was 
obtained as brown solid (1.9 g, 94 %). 1H NMR (300 MHz, CDCl3):  = 5.63 
(s, 2H), 7.47-7.50 (m, 2H), 8.09-8.12 (m, 2H); 13C NMR (75.5 MHz, 
CDCl3):  = 104.1 (C), 122.5 (2-CH), 127.1 (2-CH), 134.5 (C), 143.3 (C); 
HRMS: (EI, 70 eV): calcd for C10H6 Br2O2[M+]: 315.2741; found: 315.2745. 
6.4.5 2,3-Dibromonaphthalene-1,4-diyl bis(trifluoromethanesulfonate) (39); 
To a solution of 39 (1.0 equiv.) in CH2Cl2 (2.5 ml/mmol) was added pyridine  (2.0 equiv.) at 
20 °C under an argon atmosphere. After stirring for 10 min at 0 °C, Tf2O (1.5 equiv.) was 
added. The mixture was allowed to warm to 20 °C and stirred for further 6 h. The reaction 
mixture was filtered and the filtrate was concentrated in vacuo. The residue was directly 
purified by chromatography without aqueous work up (flash silica gel, heptane/EtOAc). 
2,3-Dibromonaphthalene-1,4-diyl bis(trifluoromethanesulfonate) (39); Starting with 38 
(1.0 g, 1.0 equiv.) in CH2Cl2 (25 ml), pyridine  (1.0 ml, 1.5 mmol) and Tf2O 
(2.7 ml, 2.5 equiv.), following the general procedure H, compound 39 was 
obtained as white crystalline solid (1.77 g, 96 %). 1H NMR (300 MHz, 
CDCl3):  = 7.69-7.72 (m, 2H), 8.10-8.13 (m, 2H); 19F NMR (282.4 MHz, 
CDCl3): δ = -71; 13C NMR (75.5 MHz, CDCl3): δ = 116.1 (2C), 118.8 (q, JF,C = 319.0 Hz, 
2CF3), 122.2 (2-CH), 127.3 (2C), 129.9 (2-CH), 142.6; GC-MS: (EI, 70eV): m/z (%) = (M+, 
582 (100), 449 (51), 385 (66), 357 (43), 237 (72), 207 (60), 181 (40); HRMS: (EI, 70 eV): 
calcd for C12H4Br2F6O6S2[M+]: 581.7694 found: 581.7691. 
6.4.6 2,3-Bis(2-methoxyphenyl)naphthalene-1,4-dione (41a); 
General procedure B for Suzuki–Miyaura reactions: A 1,4-dioxane (5 ml) solution of 
K3PO4 (1.5 equiv. per cross-coupling step), Pd(PPh3)4 (5 mol %) and aryl-boronic acid (1.0-
1.1 equiv. per cross-coupling step) was stirred at 90-110 °C for 4 h. With out aqua workup the 
DCM filtrate was concentrated in vacuo. The residue was purified by column chromatography 
(flash silica gel, heptane-EtOAc 9:1).  
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2,3-Bis(2-methoxyphenyl)naphthalene-1,4-dione (41a); Starting with 39 (100 mg, 0.17 
mmol), 2-methoxyphenylboronic acid (60 mg, 2.0 equiv.), 
Pd(PPh3)4 (12 mg, 5 mol %), K3PO4 (216 mg, 3.0 equiv.) and 1,4-
dioxane (5 ml), following the general procedure B, 41a was 
obtained (45.2 mg,  60 %). 1H NMR (300 MHz, CDCl3):  = 3.78 (s, 
6H, CH3), 6.66 (d, J = 8.8 Hz, 2H), 6.82 (d, J = 2.6 Hz, 2H), 7.11 
(dd, J = 8.8, 2.4 Hz, 2H), 7.69-7.72 (m, 2H),  8.08-8.11 (m, 2H); 13C 
NMR (75.5 MHz, CDCl3): δ = 55.8 (2-OCH3),  111.7 (2-CH), 124.6 (2C), 124.9 (2C), 126.7 
(2-CH), 129.1, (2-CH), 129.7 (2-CH), 132.6 (2C), 133.7 (2-CH), 144.6 (2C),155.2 (2C), 
183.3 (2CO); GC-MS: (EI, 70eV): m/z (%) = (M+, 438 (98), 407 (67), 372 (56); HRMS: (EI, 
70 eV): calcd for C24H16Cl2O4[M+]: 438.0427; found: 438.0426. 
2,3-Bis(4-methoxyphenyl)naphthalene-1,4-dione (41b); Starting with 39 (100 mg, 0.17 
mmol), 4-methoxyphenylboronic acid (60 mg, 2.0 equiv.), 
Pd(PPh3)4 (12 mg, 5 mol %), K3PO4 (216 mg, 3.0 equiv.)and 1,4-
dioxane (5 ml), following the general procedure B, 41b was 
obtained (44.6 mg, 70 %). 1H NMR (300 MHz, CDCl3):   = 3.71 
(s, 6H, OCH3),  6.68-6.73 (m, 4H), 6.93-6.98 (m, 4H), 7.68-7.71 
(m, 2H),  8.09-8.12 (m, 2H); 13C NMR (75.5 MHz, CDCl3): δ = 53.2 (2-OCH3), 108.1 (4-
CH), 120.4 (2C), 121.3 (4-CH), 128.4 (2-CH), 131.3 (2C), 132.6 (2C), 139.5 (2-CH), 154.1 
(2C), 179.9, (2CO); GC-MS: (EI, 70eV): m/z (%) = (M+, 370 (98), 311 (67); HRMS: (EI, 70 
eV): calcd for C24H18O4[M+]: 370.7315; found: 370.7311. 
2,3-Di-p-tolylnaphthalene-1,4-dione (41c); Starting with 39 (100 mg, 0.17 mmol), 4-
methylphenylboronic acid (45 mg, 2.0 equiv.), Pd(PPh3)4 (12 mg, 
5 mol %), K3PO4 (216 mg, 3.0 equiv.) and 1,4-dioxane (5 ml), 
following the general procedure B, 41c was obtained (43 mg, 74 
%). 1H NMR (300 MHz, CDCl3):  = 2.22 (s, 6H, CH3), 7.89 (dd, 
J = 8.2, 3.3 Hz, 4H), 7.81 (dd, J = 8.1, 3.4 Hz, 4H), 7.66-7.71 (m, 
2H), 8.07-8.11 (m, 2H); 13C NMR (75.5 MHz, CDCl3): δ = 21.3 (2-CH3), 126.6 (2C), 127.3 
(2-CH), 128.4 (4-CH), 130.5 (4-CH), 132.2 (2C), 133.7 (2CH), 138.1 (2C), 145.5 (2C), 184.9 
(2CO); GC-MS: (EI, 70eV): m/z (%) = (M+,  338 (92), 156 (63); HRMS: (EI, 70 eV): calcd 
for C24H18O2[M+]: 338.2362; found: 338.2357. 
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2,3-Bis(2-chlorophenyl)naphthalene-1,4-dione (41d); Starting with 39 (100 mg, 0.17 
mmol), 2-chlorophenylboronic acid (50 mg, 2.0 equiv.), Pd(PPh3)4 (12 
mg, 5 mol %), K3PO4 (216 mg, 3.0 equiv.) and 1,4-dioxane (5 ml), 
following the general procedure B, 41d was obtained (41.6 mg, 64 %). 1H 
NMR (300 MHz, CDCl3):  = 7.12 (dd, J = 8.6, 2.7  Hz, 4H), 7.09-7.15  
(m, 2H), 7.28 (d, J = 8.6 Hz, 2H), 8.73-7.76 (m, 2H), 8.13-8.16 (m, 2H); 
13C NMR (75.5 MHz, CDCl3): δ = 125.7 (2-CH), 125.9 (2-CH), 127.9 (2-CH), 128.2 (2-CH), 
128.9 (2-CH), 131.1 (2C), 132.0 (2C), 132.8 (2C), 145.0 (2C), 182.3 (2CO); GCMS: (EI, 
70eV): m/z (%) = (M+, 378 (97); HRMS: (EI, 70 eV): calcd for C22H12Cl2O2[M+]: 378.1754; 
found: 378.1751. 
2,3-Diphenylnaphthalene-1,4-dione (41e); Starting with 39 (100 mg, 0.17 mmol), 
phenylboronic acid (42 mg, 2.0 equiv.), Pd(PPh3)4 (12 mg, 5 mol %), 
K3PO4 (216 mg, 3.0 equiv.) and 1,4-dioxane (5 ml), following the 
general procedure B, 41e was obtained (37 mg, 70 %). 1H NMR (300 
MHz, CDCl3):  = 7.05-7.11 (m, 4H), 7.19-7.27 (m, 6H), 7.76-7.82 (m, 
2H), 8.17-8.23 (m, 2H); 13C NMR (75.5 MHz, CDCl3): δ = 123.7 (4-CH), 125.6 (4-CH), 
127.9 (2-CH), 128.2 (2CH), 128.9 (2C), 131.1 (2C), 132.8 (2C), 181.3 (2CO); GC-MS: (EI, 
70eV): m/z (%) = (M+, 310 (92); HRMS: (EI, 70 eV): calcd for C22H14O2[M+]: 310.2561; 
found: 310.2557. 
6.4.7 2-Bromonaphthalene-1,4-diol (43); 
2-Bromonaphthalene-1,4-diol (43); Starting with 42 (1.0 g, 1.0 equiv.), Na2S2O4 (5.00 g), 
following the general procedure K, compound 43 was obtained as brownish 
solid (0.9 g, 88 %). 1H NMR (300 MHz, CDCl3):  = 5.68 (s, 2H), 6.73 (s, 
1H), 7.62-7.63 (m, 2H), 8.14-8.17 (m, 2H); 13C NMR (75.5 MHz, CDCl3):  
= 104.1 (C), 105.3 (C), 122.5 (2-CH), 127.1 (2-CH), 131.5 (CH), 134.5 (C), 
143.3 (2C); HRMS: (EI, 70 eV): calcd for C10H7BrO2[M+]: 237.1643;  found: 237.1643. 
6.4.8 2-Bromonaphthalene-1,4-diyl bis(trifluoromethanesulfonate) (44); 
To a solution of 39 (1.0 equiv.) in CH2Cl2 (2.5 ml/mmol) was added pyridine  (2.0 equiv.) at 
20 °C under an argon atmosphere. After stirring for 10 min at 0 °C, Tf2O (1.5 equiv.) was 
added. The mixture was allowed to warm to 20 °C and stirred for further 6 h. The reaction 
mixture was filtered and the filtrate was concentrated in vacuo. The residue was directly 
purified by chromatography without aqueous work up (flash silica gel, heptane/EtOAc). 
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2-Bromonaphthalene-1,4-diyl bis(trifluoromethanesulfonate) (44); Starting with 38 (0.5 g, 
1.0 equiv.) in CH2Cl2 (15 ml), pyridine  (0.5 ml, 0.8 mmol) and Tf2O (1.5 
ml, 2.5 equiv.), following the general procedure H, 44 was obtained (0.7 g, 88 
%). 1H NMR (300 MHz, CDCl3):  = 7.69-7.72 (m, 3H), 8.10-8.13 (m, 2H); 
19F NMR (282.4 MHz, CDCl3): δ = -73; 13C NMR (75.5 MHz, CDCl3): 
δ = 109.6 (CH), 115.7 (2-CH), 118.8 (q, JF,C = 317.0 Hz, 2CF3), 122.2 (2-CH), 127.3 (2C), 
128.9 (C), 141.3 (C), 142.6 (C); GC-MS: (EI, 70eV): m/z (%) = (M+, 502 (97), 124 (61); 
HRMS: (EI, 70 eV): calcd for C12H5BrF6O6S2[M+]: 501.8773;  found: 501.8769. 
General procedure B for Suzuki–Miyaura reactions: A 1,4-dioxane (5 ml) solution of 
K3PO4 (1.5 equiv. per cross-coupling step), Pd(PPh3)4 (5 mol%) and aryl-boronic acid 16a-h 
(1.0-1.1 equiv. per cross-coupling step) was stirred at 90-110 °C for 4 h. After cooling to 20 
°C, with out work up the DCM filtrate was concentrated in vacuo. The residue was purified 
by column chromatography (flash silica gel, heptane-EtOAc 9:1). 
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Appendix 
7 Crystallographic Data 
7.1 Crystal data and structure refinement for 2,8-Bis(methoxycarbonyl)-3,6-
dichlorobenzo[1,2-b;5,6-b']dithiophene (2) 
 
Identification code  zh-145 
Empirical formula  C14H8Cl2O4S2 
Formula weight  375.22  
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group (H.-M.)  F d d 2 
Space group (Hall)  F 2 -2d 
Unit cell dimensions a = 51.286 (4) Å α = 90.00°. 
 b = 3.8608 (3) Å β = 90.00°. 
 c = 14.4525 (9)Å γ = 90.00°. 
Volume 2861.6(3) Å3 
Z 8 
Density (calculated) 1.742 Mg/m3 
Absorption coefficient 0.759 mm-1 
F(000) 1520 
 range for data collection 4.910 to 40.817°. 
Reflections collected 1870 
Independent reflections 1732 [R(int) = 0.026] 
Absorption correction multi-scan 
Max. and min. transmission 0.9975 and 0.9127 
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7.2 Crystal data and structure refinement for 2,7-Bis(butoxycarbonyl)-3,6-
dichlorobenzo[1,2-b;5,6-b']dithiophene (3) 
 
Identification code  zh-260 
Empirical formula  C20H20Cl2O4S2  
Formula weight   459.38 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  C 2/c 
Space group (Hall)  C 2yc 
Unit cell dimensions a = 17.2094 (12) Å α = 90.00° 
 b = 12.1821 (8) Å β = 91.956 (3)° 
 c = 10.0334 (6) Å γ = 90.00°. 
Volume 2102.2(2) Å3 
Z 4 
Density (calculated) 1.451 Mg/m3 
Absorption coefficient 0.531 mm-1 
F(000) 952 
Crystal size 0.45 × 0.08 × 0.06 mm3 
 range for data collection 5.7–58.8°. 
Reflections collected 2499 
Independent reflections 2986 [R(int) = 0.032] 
Absorption correction multi-scan 
Max. and min. transmission 0.9924 and 0.9700 
Refinement method Full-matrix  
Goodness-of-fit on F2 0.0690 
Final R indices [I>2 (I)] R1 = 0.0477, wR2 = 0.1157 
R indices (all data) R1 = 0.0879, wR2 = 0.1271 
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7.3   Crystal data and structure refinement for 2-(4-Fluorophenyl)naphthalen-1-yl             
trifluoromethanesulfonate (17e) 
 
Identification code  zh-67 
Empirical formula  C17H10F4O3S 
Formula weight  370.31  
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P 21/c 
Space group (Hall)  -P 2ybc 
Unit cell dimensions a = 15.3267(9) Å α = 90.00°. 
 b = 13.8391(8) Å β = 103.902(2)°. 
 c = 7.7406(4) Å γ = 90.00°. 
Volume 1593.75(16) Å3 
Z 4 
Density (calculated) 1.543 Mg/m3 
Absorption coefficient 0.260 mm-1 
F(000) 752 
Crystal size 0.34 × 0.24 × 0.18 mm3 
 range for data collection 5.9–54.1°. 
Reflections collected 16730 
Independent reflections 4253 [R (int) = 0.042] 
Absorption correction multi-scan 
Max. and min. transmission 2.74 and 29.1 
Refinement method Full-matrix  
Goodness-of-fit on F2 1.065 
Final R indices [I>2 (I)] R1 = 0.0432, wR2 = 0.1071 
R indices (all data) R1 = 0.0663, wR2 = 0.1153 
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7.4 Crystal data and structure refinement for 2-(4-Chlorophenyl)-1-(3, 5-
dimethylphenyl) naphthalene (18d) 
 
Identification code  zh-103a 
Empirical formula  C24H19Cl 
Formula weight  342.84  
Temperature  173(2) K 
Wavelength  0.71073Å 
Crystal system  Triclinic 
Space group (H.-M.)  P -1 
Space group (Hall)  -P 1 
Unit cell dimensions a = 6.4048 (4) Å α = 98.989 (3)° 
 b = 10.9621 (5) Å β = 92.056 (3)° 
 c = 13.4750 (7) Å γ = 104.637(2)° 
Volume 901.32 (8) Å3 
Z 2 
Density (calculated) 1.263 Mg/m3 
Absorption coefficient 0.214 mm-1 
F(000) 360 
Crystal size 0.99 × 0.12 × 0.04 mm3 
 range for data collection 5.4–58.8°. 
Reflections collected 4748 
Independent reflections 2590 [R(int) = 0.066] 
Absorption correction multi-scan 
Max. and min. transmission 0.992 and 0.816 
Refinement method Full-matrix  
Goodness-of-fit on F2 1.066 
Final R indices [I>2 (I)] R1 = 0.049, wR2 = 0.1480 
R indices (all data) R1 = 0.0778, wR2 = 0.1342 
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7.5 Crystal data and structure refinement for 1, 2-Bis(4-methylphenyl)naphthalen (19b) 
 
Identification code  zh-74 
Empirical formula  C24H20 
Formula weight  308.40  
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P 21/c 
Space group (Hall)  -P 2ybc 
Unit cell dimensions a = 6.562(2) Å α = 90.00°. 
 b = 10.835(3) Å β = 93.020 (15)°. 
 c = 25.028(8) Å γ = 90.00°. 
Volume 1777.0 (10) Å3 
Z 4 
Density (calculated) 1.153 Mg/m3 
Absorption coefficient 0.065 mm-1 
F(000) 656 
Crystal size 0.80 × 0.24 × 0.12 mm3 
 range for data collection 5.0–56.7°. 
Reflections collected 14259 
Independent reflections 4007 [R (int) = 0.0374] 
Absorption correction multi-scan 
Max. and min. transmission 0.9499 and 0.9922 
Refinement method Full-matrix  
Goodness-of-fit on F2 1.053 
Final R indices [I>2 (I)] R1 = 0.0767, wR2 = 0.1411 
R indices (all data) R1 = 0.0492, wR2 = 0.1287 
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7.6 Crystal data and structure refinement for 1, 2-Bis(4-chlorophenyl)naphthalene (19c) 
 
Identification code  zh-66 
Empirical formula  C22H14Cl2 
Formula weight  349.23  
Temperature  173 (2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P 21/c 
Space group (Hall)  -P 2ybc 
Unit cell dimensions a = 6.4479(2) Å α = 90.00°. 
 b = 11.1817(4) Å β = 90.344 (2)°. 
 c = 23.3422(8) Å γ = 90.00°. 
Volume 1682.91(10) Å3 
Z 4 
Density (calculated) 1.378 Mg/m3 
Absorption coefficient 0.385 mm-1 
F(000) 720 
Crystal size 0.40 x 0.13 x 0.10 mm3 
 range for data collection 5.045 to 59.364°. 
Reflections collected 5277 
Independent reflections 3188 [R (int) = 0.0278] 
Absorption correction multi-scan 
Max. and min. transmission 0.8614 and 0.9626 
Refinement method Full-matrix  
Goodness-of-fit on F2 1.045 
Final R indices [I>2 (I)] R1 = 0.0429, wR2 = 0.0923 
R indices (all data) R1 = 0.0821, wR2 = 0.1013 
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7.7 Crystal data and structure refinement for Synthesis of 1-(4-Bromo-1-
hydroxynaphthalen-2-yl)ethanone (25) 
 
Identification code  zh-104 
Empirical formula  C12H9BrO2 
Formula weight  265.10  
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P 21/c 
Space group (Hall)  -P 2ybc 
Unit cell dimensions a = 10.4784(2) Å α = 90.00°. 
 b = 14.4026(3) Å β = 108.9280 (10)°. 
 c = 7.0563(2) Å γ = 90.00°. 
Volume 1007.33(4) Å3 
Z 4 
Density (calculated) 1.153 Mg/m3 
Absorption coefficient 4.054 mm-1 
F(000) 528 
Crystal size 0.67 × 0.18 × 0.06 mm3 
 range for data collection 5.0–72.0°. 
Reflections collected 14554 
Independent reflections 2922 [R (int) = 0.0268] 
Absorption correction multi-scan 
Max. and min. transmission 2.83 and 30.00 
Refinement method Full-matrix  
Goodness-of-fit on F2 1.053 
Final R indices [I>2 (I)] R1 = 0.0258, wR2 = 0.0702 
R indices (all data)                                    R1 = 0.0348, wR2 = 0.0734 
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7.8 Crystal data and structure refinement for 6H-[1]benzothieno[2,3-C]chromen-6-ones  
(36a) 
 
Identification code  zh-22 
Empirical formula  C15H8O2S 
Formula weight  252.27  
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group (H.-M.)  P 21 21 21 
Space group (Hall)  P 2ac 2ab 
Unit cell dimensions a = 3.8891 (3) Å α = 90°. 
 b = 15.1701 (12) Å β = 90°. 
 c = 18.5215 (16) Å γ = 90°. 
Volume 1092.73 (15) Å3 
Z 4 
Density (calculated) 1.533 Mg/m3 
Absorption coefficient 0.284 mm-1 
F(000) 520 
Crystal size 0.95 × 0.13 × 0.09 mm3 
 range for data collection 5.2–58.3° 
Reflections collected 3859 
Independent reflections 864 [R(int) = 0.109] 
Absorption correction multi-scan 
Max. and min. transmission 0.7745 and 0.9749 
Refinement method Full-matrix  
Goodness-of-fit on F2 1.03 
Final R indices [I>2 (I)] R1 = 0.0400, wR2 = 0.0858 
R indices (all data) R1 = 0.0617, wR2 = 0.0792 
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5.8 Crystal data and structure refinement for 2,3-Dibromonaphthalene-1,4-diyl   
bis(trifluoromethanesulfonate) (39) 
 
Identification code  zh-93 
Empirical formula  C12H4Br2F6O6S2 
Formula weight  582.09  
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  C 2/c 
Space group (Hall)  -C 2yc 
Unit cell dimensions a = 26.7321(13) Å α = 90°. 
 b = 5.9885(2) Å β = 115.335 (2). 
 c = 24.5279(12) Å γ = 90°. 
Volume 3548.9(3) Å3 
Z 8 
Density (calculated) 2.179 Mg/m3 
Absorption coefficient 4.894 mm-1 
F(000) 2240 
Crystal size 0.51 × 0.06 × 0.02 mm3 
 range for data collection 2.98– 26.50° 
Reflections collected 2414 
Independent reflections 3692 [R(int) = 0.0606] 
Absorption correction multi-scan 
Max. and min. transmission 0.9085 and 0.1892 
Refinement method Full-matrix  
Goodness-of-fit on F2 0.974 
Final R indices [I>2 (I)] R1 = 0.0818, wR2 = 0.0733 
R indices (all data) R1 = 0.0871, wR2 = 0.0414 
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Abbreviations  
Ac  Acetyl  
Anal.  Elemental Analysis  
bp.  Boiling point  
calcd  Calculated  
CI  Chemical Ionization  
COSY  Correlated Spectroscopy  
DEPT  Distortionless Enhancement by Polarization Transfer  
dr  Diastereomeric ratio  
ee  Enantiomeric excess  
EI  Electron Impact   
Et2O  Diethyl ether  
EtOH  Ethanol  
GC  Gas Chromatography  
GP  General Procedure  
HMBC Heteronuclear Multiple Bond Correlation  
HPLC  High Performance Liquid Chromatography  
HRMS  High Resolution Mass Spectrometry  
IR  Infrared Spectroscopy  
MS  Mass Spectrometry  
mp  Melting point  
NaOEt  Sodium ethanolate  
nBuLi  n-Butyllithium  
NEt3  Triethylamine  
NMR  Nuclear Magnetic Resonance  
NOESY Nuclear Overhauser and Exchange Spectroscopy 
ORTEP Oak Ridge Thermal Ellipsoid Plot   
OTf  Triflate  
Ph  Phenyl  
ppm  Parts per million  
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Rf  Retention factor  
Tf2O  Trifluoromethanesulfonic anhydride (triflic anhydride) 
TFA  Trifluoroacetic acid  
THF  Tetrahydrofuran  
TLC  Thin Layer Chromatography  
TMS   Tetramethylsilane  
Tol  Tolyl (p-MeC6H4)  
Tos  Tosyl (p-MeC6H4SO2
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